Exact Mass: 371.1288

Exact Mass Matches: 371.1288

Found 500 metabolites which its exact mass value is equals to given mass value 371.1288, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Trazodone

2-{3-[4-(3-chlorophenyl)piperazin-1-yl]propyl}-2H,3H-[1,2,4]triazolo[4,3-a]pyridin-3-one

C19H22ClN5O (371.1513)


A serotonin uptake inhibitor that is used as an antidepressive agent. It has been shown to be effective in patients with major depressive disorders and other subsets of depressive disorders. It is generally more useful in depressive disorders associated with insomnia and anxiety. This drug does not aggravate psychotic symptoms in patients with schizophrenia or schizoaffective disorders. (From AMA Drug Evaluations Annual, 1994, p309) CONFIDENCE standard compound; INTERNAL_ID 712; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7040; ORIGINAL_PRECURSOR_SCAN_NO 7038 CONFIDENCE standard compound; INTERNAL_ID 712; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 6960; ORIGINAL_PRECURSOR_SCAN_NO 6956 CONFIDENCE standard compound; INTERNAL_ID 712; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7037; ORIGINAL_PRECURSOR_SCAN_NO 7034 CONFIDENCE standard compound; INTERNAL_ID 712; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 6996; ORIGINAL_PRECURSOR_SCAN_NO 6993 D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017367 - Selective Serotonin Reuptake Inhibitors D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent N - Nervous system > N06 - Psychoanaleptics > N06A - Antidepressants CONFIDENCE standard compound; INTERNAL_ID 2271 D049990 - Membrane Transport Modulators Trazodone (AF-1161 free base) is a serotonin receptor antagonist and reuptake inhibitor. Trazodone can be used for the research of major depressive disorder. Trazodone also has potential for sleep disorder research[1].

   

1,2,3,10-Tetramethoxy-7-(methylamino)-6,7-dihydro-5H-benzo[a]heptalen-9-one

3,4,5,14-tetramethoxy-10-(methylamino)tricyclo[9.5.0.0²,⁷]hexadeca-1(16),2,4,6,11,14-hexaen-13-one

C21H25NO5 (371.1733)


ATC code: L01CC01 Colcemid (Demecolcine) is a potent mitotic inhibitor with an IC50 value of 2.4 μM for inhibition of tubulin polymerization. Colcemid (Demecolcine) can interact with tubulin dimers to induce anti-mitotic action and inhibit microtubule growth. Colcemid (Demecolcine) can be used for inflammatory disorders and cancer research[1][2]. Colcemid (Demecolcine) is a potent mitotic inhibitor with an IC50 value of 2.4 μM for inhibition of tubulin polymerization. Colcemid (Demecolcine) can interact with tubulin dimers to induce anti-mitotic action and inhibit microtubule growth. Colcemid (Demecolcine) can be used for inflammatory disorders and cancer research[1][2].

   

Salutaridinol acetate

7-O-Acetylsalutaridinol; Salutaridinol acetate; Salutaridinol 7-O-acetate

C21H25NO5 (371.1733)


   

Nedocromil

9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)quinoline-2,8-dicarboxylic acid

C19H17NO7 (371.1005)


Nedocromil is only found in individuals that have used or taken this drug. It is a pyranoquinolone derivative that inhibits activation of inflammatory cells which are associated with asthma, including eosinophils, neutrophils, macrophages, mast cells, monocytes, and platelets. [PubChem]Nedocromil has been shown to inhibit the in vitro activation of, and mediator release from, a variety of inflammatory cell types associated with asthma, including eosinophils, neutrophils, macrophages, mast cells, monocytes, and platelets. Nedocromil inhibits activation and release of inflammatory mediators such as histamine, prostaglandin D2 and leukotrienes c4 from different types of cells in the lumen and mucosa of the bronchial tree. These mediators are derived from arachidonic acid metabolism through the lipoxygenase and cyclo-oxygenase pathways. The mechanism of action of nedocromil may be due partly to inhibition of axon reflexes and release of sensory neuropeptides, such as substance P, neurokinin A, and calcitonin-geneñrelated peptides. The result is inhibition of bradykinin-induced bronchoconstriction. Nedocromil does not posess any bronchodilator, antihistamine, or corticosteroid activity. R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03B - Other drugs for obstructive airway diseases, inhalants > R03BC - Antiallergic agents, excl. corticosteroids R - Respiratory system > R01 - Nasal preparations > R01A - Decongestants and other nasal preparations for topical use > R01AC - Antiallergic agents, excl. corticosteroids S - Sensory organs > S01 - Ophthalmologicals > S01G - Decongestants and antiallergics C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist D000893 - Anti-Inflammatory Agents > D000082142 - Mast Cell Stabilizers D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents D018926 - Anti-Allergic Agents D007155 - Immunologic Factors Nedocromil suppresses the action or formation of multiple mediators, including histamine, leukotriene C4 (LTC4), and prostaglandin D2 (PGD2).

   

Capaurine

(13aS)-2,3,9,10-tetramethoxy-6,8,13,13a-tetrahydro-5H-isoquinolino[2,1-b]isoquinolin-1-ol

C21H25NO5 (371.1733)


   
   

Isoandrocymbine

(1R,10S)-5-hydroxy-3,4,14-trimethoxy-18-methyl-18-azatetracyclo[8.5.3.01,11.02,7]octadeca-2,4,6,11,14-pentaen-13-one

C21H25NO5 (371.1733)


Isoandrocymbine is an isoquinoline alkaloid. Isoandrocymbine has been reported in Colchicum autumnale

   
   

Berberine chloride

Berberine hydrochloride

C20H18NO4. Cl (371.0924)


Berberine chloride is an alkaloid that acts as an antibiotic. Berberine chloride induces reactive oxygen species (ROS) generation and inhibits DNA topoisomerase. Antineoplastic properties[1]. Berberine chloride is an alkaloid that acts as an antibiotic. Berberine chloride induces reactive oxygen species (ROS) generation and inhibits DNA topoisomerase. Antineoplastic properties[1].

   

Ampicillin sodium

Ampicillin sodium

C16H18N3O4S. Na (371.0916)


D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic Same as: D02119

   

isradipine

Isradipine (Dynacirc)

C19H21N3O5 (371.1481)


C - Cardiovascular system > C08 - Calcium channel blockers > C08C - Selective calcium channel blockers with mainly vascular effects > C08CA - Dihydropyridine derivatives C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker

   

Isradipine

3-methyl 5-propan-2-yl 4-(2,1,3-benzoxadiazol-4-yl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate

C19H21N3O5 (371.1481)


Isradipine belongs to the dihydropyridine (DHP) class of calcium channel blockers (CCBs), the most widely used class of CCBs. It is structurally related to felodipine, nifedipine, and nimodipine and is the most potent calcium-channel blocking agent of the DHP class. Isradipine binds to calcium channels with high affinity and specificity and inhibits calcium flux into cardiac and arterial smooth muscle cells. It exhibits greater selectivity towards arterial smooth muscle cells owing to alternative splicing of the alpha-1 subunit of the channel and increased prevalence of inactive channels in smooth muscle cells. Isradipine may be used to treat mild to moderate essential hypertension. C - Cardiovascular system > C08 - Calcium channel blockers > C08C - Selective calcium channel blockers with mainly vascular effects > C08CA - Dihydropyridine derivatives C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker

   

N-[2-(3,4-Dimethoxyphenyl)ethyl]-3,4-dimethoxycinnamic acid amide

(2E)-3-(3,4-Dimethoxyphenyl)-N-[2-(3,4-dimethoxyphenyl)ethyl]prop-2-enimidate

C21H25NO5 (371.1733)


N-[2-(3,4-Dimethoxyphenyl)ethyl]-3,4-dimethoxycinnamic acid amide is used as a food additive [EAFUS] ("EAFUS: Everything Added to Food in the United States. [http://www.eafus.com/]")

   

N-Methyl-14-O-demethylepiporphyroxine

17-methoxy-22-methyl-6,8,12-trioxa-22-azapentacyclo[11.9.0.0²,¹⁰.0⁵,⁹.0¹⁴,¹⁹]docosa-2(10),3,5(9),14,16,18-hexaene-11,16-diol

C20H21NO6 (371.1369)


N-Methyl-14-O-demethylepiporphyroxine is an alkaloid from Papaver somniferum (opium poppy

   

4-(2-amino-3-hydroxyphenyl)-4-oxobutanoic acid O-glucoside

4-(2-amino-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)-4-oxobutanoic acid

C16H21NO9 (371.1216)


4-(2-amino-3-hydroxyphenyl)-4-oxobutanoic acid O-glucoside, also known as 4-AHPh-oba-glu, is classified as a member of the Phenolic glycosides. Phenolic glycosides are organic compounds containing a phenolic structure attached to a glycosyl moiety. Some examples of phenolic structures include lignans, and flavonoids. Among the sugar units found in natural glycosides are D-glucose, L-Fructose, and L rhamnose. 4-(2-amino-3-hydroxyphenyl)-4-oxobutanoic acid O-glucoside is considered to be slightly soluble (in water) and acidic

   

Salicyluric beta-D-glucuronide

(2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-({2-[(2-hydroxyphenyl)formamido]acetyl}oxy)oxane-2-carboxylic acid

C15H17NO10 (371.0852)


Salicyluric beta-D-glucuronide, also known as 1-O-salicyluroyl-beta-D-glucuronate or 1-O-[N-(2-hydroxybenzoyl)glycyl]-beta-D-glucronate, is a member of the class of compounds known as O-glucuronides. O-glucuronides are glucuronides in which the aglycone is linked to the carbohydrate unit through an O-glycosidic bond.

   

2-Methoxy-4-(2-(methylamino)propyl)phenyl beta-D-glucopyranosiduronic acid

3,4,5-trihydroxy-6-{2-methoxy-4-[2-(methylamino)propyl]phenoxy}oxane-2-carboxylic acid

C17H25NO8 (371.158)


   

2-[6-(4-Chlorophenoxy)hexyl]-1-cyano-3-pyridin-4-ylguanidine

N-[6-(4-chlorophenoxy)hexyl]-N-cyano-N-(pyridin-4-yl)guanidine

C19H22ClN5O (371.1513)


C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor

   

4-Dedimethylamino sancycline

1,10,11,12a-tetrahydroxy-3,12-dioxo-3,4,4a,5,5a,6,12,12a-octahydrotetracene-2-carboxamide

C19H17NO7 (371.1005)


   

4-(1-Isopropyl-2-methyl-1H-imidazol-5-yl)-N-(4-(methylsulfonyl)phenyl)pyrimidin-2-amine

N-(4-methanesulfonylphenyl)-4-[2-methyl-1-(propan-2-yl)-1H-imidazol-5-yl]pyrimidin-2-amine

C18H21N5O2S (371.1416)


   

Abt-751

N-{2-[(4-hydroxyphenyl)amino]pyridin-3-yl}-4-methoxybenzene-1-sulphonamide

C18H17N3O4S (371.094)


C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C273 - Antimitotic Agent

   

Amocarzine

4-methyl-N-{4-[(4-nitrophenyl)amino]phenyl}piperazine-1-carbothioamide

C18H21N5O2S (371.1416)


D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000871 - Anthelmintics C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C250 - Antihelminthic Agent

   

Azaribine

[3,4-bis(acetyloxy)-5-(3,5-dioxo-2,3,4,5-tetrahydro-1,2,4-triazin-2-yl)oxolan-2-yl]methyl acetate

C14H17N3O9 (371.0965)


   

Baricitinib

2-[1-(Ethanesulphonyl)-3-(4-{1h-pyrrolo[2,3-D]pyrimidin-4-yl}-1H-pyrazol-1-yl)azetidin-3-yl]acetonitrile

C16H17N7O2S (371.1164)


L - Antineoplastic and immunomodulating agents > L04 - Immunosuppressants > L04A - Immunosuppressants > L04AA - Selective immunosuppressants C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor COVID info from Guide to PHARMACOLOGY, clinicaltrial, clinicaltrials, clinical trial, clinical trials, DrugBank C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C172200 - JAK Inhibitor Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

Darodipine

3,5-Diethyl 4-(2,1,3-benzoxadiazol-4-yl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid

C19H21N3O5 (371.1481)


C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker

   

Lenperone

4-[4-(4-fluorobenzoyl)piperidin-1-yl]-1-(4-fluorophenyl)butan-1-one

C22H23F2NO2 (371.1697)


C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent

   

N-(9H-Fluoren-9-ylacetyl)-L-phenylalanine

2-{[2-(9H-fluoren-9-yl)-1-hydroxyethylidene]amino}-3-phenylpropanoate

C24H21NO3 (371.1521)


   

N-Hydroxymexiletine glucuronide

6-({[1-(2,6-dimethylphenoxy)propan-2-yl]amino}oxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

C17H25NO8 (371.158)


   

2-[4-[(2,5-Difluorophenyl)methoxy]phenoxy]-5-ethoxyaniline

2-(4-((2,5-Difluorophenyl)methoxy)phenoxy)-5-ethoxyaniline

C21H19F2NO3 (371.1333)


   

(3z)-N,N-Dimethyl-2-Oxo-3-(4,5,6,7-Tetrahydro-1h-Indol-2-Ylmethylidene)-2,3-Dihydro-1h-Indole-5-Sulfonamide

(3Z)-N,N-Dimethyl-2-oxo-3-(4,5,6,7-tetrahydro-1H-indol-2-ylmethylidene)-2,3-dihydro-1H-indole-5-sulphonamide

C19H21N3O3S (371.1304)


   

Triaminophenyl phosphate

Tris(4-aminophenyl) phosphoric acid

C18H18N3O4P (371.1035)


   

Hydroxydesmethylpiperine sulfate

{2-hydroxy-5-[(1E)-5-(4-hydroxypiperidin-1-yl)-5-oxopent-1-en-1-yl]phenyl}oxidanesulphonic acid

C16H21NO7S (371.1039)


   

1ST40203A

16,17-dimethoxy-5,7-dioxa-13lambda5-azapentacyclo[11.8.0.0^{2,10}.0^{4,8}.0^{15,20}]henicosa-1(21),2(10),3,8,13,15(20),16,18-octaen-13-ylium chloride

C20H18ClNO4 (371.0924)


Berberine chloride (TN) is an organic molecular entity. Berberine Chloride is the orally bioavailable, hydrochloride salt form of berberine, a quaternary ammonium salt of an isoquinoline alkaloid and active component of various Chinese herbs, with potential antineoplastic, radiosensitizing, anti-inflammatory, anti-lipidemic and antidiabetic activities. Although the mechanisms of action through which berberine exerts its effects are not yet fully elucidated, upon administration this agent appears to suppress the activation of various proteins and/or modulate the expression of a variety of genes involved in tumorigenesis and inflammation, including, but not limited to transcription factor nuclear factor-kappa B (NF-kB), myeloid cell leukemia 1 (Mcl-1), B-cell lymphoma 2 (Bcl-2), B-cell lymphoma-extra large (Bcl-xl), cyclooxygenase (COX)-2, tumor necrosis factor (TNF), interleukin (IL)-6, IL-12, inducible nitric oxide synthase (iNOS), intercellular adhesion molecule-1 (ICAM-1), E-selectin, monocyte chemoattractant protein-1 (MCP-1), C-X-C motif chemokine 2 (CXCL2), cyclin D1, activator protein (AP-1), hypoxia-inducible factor 1 (HIF-1), signal transducer and activator of transcription 3 (STAT3), peroxisome proliferator-activated receptor (PPAR), arylamine N-acetyltransferase (NAT), and DNA topoisomerase I and II. The modulation of gene expression may induce cell cycle arrest and apoptosis, and inhibit cancer cell proliferation. In addition, berberine modulates lipid and glucose metabolism. Berberine chloride is an alkaloid that acts as an antibiotic. Berberine chloride induces reactive oxygen species (ROS) generation and inhibits DNA topoisomerase. Antineoplastic properties[1]. Berberine chloride is an alkaloid that acts as an antibiotic. Berberine chloride induces reactive oxygen species (ROS) generation and inhibits DNA topoisomerase. Antineoplastic properties[1].

   

Diacetyl lycorine

Diacetyl lycorine

C20H21NO6 (371.1369)


   

(-)-Thaicanine

(-)-Thaicanine

C21H25NO5 (371.1733)


   

Acutifolidine

Acutifolidine

C21H25NO5 (371.1733)


   
   
   

1,2,9,10-tetramethoxy-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-3-ol

1,2,9,10-tetramethoxy-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-3-ol

C21H25NO5 (371.1733)


   
   

1-hydroxy-2,3,9,10-tetramethoxyaporphine

1-hydroxy-2,3,9,10-tetramethoxyaporphine

C21H25NO5 (371.1733)


   

(-)-Tetrahydrostephabine

(-)-Tetrahydrostephabine

C21H25NO5 (371.1733)


   
   

16-Oxodelavaine

16-Oxodelavaine

C20H21NO6 (371.1369)


   
   

Cinereapyrrole B

Cinereapyrrole B

C22H17N3O3 (371.127)


   

(-)-cis-Xylopinine N-oxide

(-)-cis-Xylopinine N-oxide

C21H25NO5 (371.1733)


   

(-)-Sukhodianine beta-N-oxide

(-)-Sukhodianine beta-N-oxide

C20H21NO6 (371.1369)


   

Ophiocarpine N-oxide

Ophiocarpine N-oxide

C20H21NO6 (371.1369)


   
   

Haplatine acetate

Haplatine acetate

C20H21NO6 (371.1369)


   
   

Antrocinnamomin A

Antrocinnamomin A

C21H25NO5 (371.1733)


   

Berkeleyamide B

Berkeleyamide B

C20H21NO6 (371.1369)


   
   

trans-N-Methylcorypalmine

trans-N-Methylcorypalmine

C21H25NO5 (371.1733)


   

5-(3-nitrophenyl)-2-phenyl-1,10b-dihydropyrazolo[1,5-c][1,3]benzoxazine

5-(3-nitrophenyl)-2-phenyl-1,10b-dihydropyrazolo[1,5-c][1,3]benzoxazine

C22H17N3O3 (371.127)


   

Fumaritine N-oxide

Fumaritine N-oxide

C20H21NO6 (371.1369)


   
   
   

N-(3-Cyano-1H-indol-5-yl)-3-[4-(trifluoromethoxy)phenyl]acrylamide

N-(3-Cyano-1H-indol-5-yl)-3-[4-(trifluoromethoxy)phenyl]acrylamide

C19H12F3N3O2 (371.0882)


   

Maybridge4_001514

Maybridge4_001514

C19H21N3O3S (371.1304)


   

CHEMBL3526290

CHEMBL3526290

C24H21NO3 (371.1521)


   
   

AZD5438

4-(1-Isopropyl-2-methyl-1H-imidazol-5-yl)-N-(4-(methylsulfonyl)phenyl)pyrimidin-2-amine

C18H21N5O2S (371.1416)


   

2-Demethyl-colchicein

2-Demethyl-colchicein

C20H21NO6 (371.1369)


   

N-(3-hydroxy-1,2,10-trimethoxy-9-oxo-6,7-dihydro-5H-benzo[a]heptalen-7-yl)formamide

N-(3-hydroxy-1,2,10-trimethoxy-9-oxo-6,7-dihydro-5H-benzo[a]heptalen-7-yl)formamide

C20H21NO6 (371.1369)


   

(7S)-6-methoxy-2-methyl-6,8,3,4-tetrahydro-2H-(7rN)-spiro[indeno[4,5-d][1,3]dioxole-7,1-isoquinoline]-6t,8t,7-triol|ledeboridine|Ledebouridin|ledebouridine

(7S)-6-methoxy-2-methyl-6,8,3,4-tetrahydro-2H-(7rN)-spiro[indeno[4,5-d][1,3]dioxole-7,1-isoquinoline]-6t,8t,7-triol|ledeboridine|Ledebouridin|ledebouridine

C20H21NO6 (371.1369)


   
   

NORPURPUREINE

NORPURPUREINE

C21H25NO5 (371.1733)


   

(+)-(S)-oconovine|(S)-Oconovine

(+)-(S)-oconovine|(S)-Oconovine

C21H25NO5 (371.1733)


   

TimTec1_001753

TimTec1_001753

C21H25NO5 (371.1733)


   

SCHEMBL20626347

SCHEMBL20626347

C18H21N5O4 (371.1593)


   
   

O-Demethylpurpurein|O-demethylpurpureine

O-Demethylpurpurein|O-demethylpurpureine

C21H25NO5 (371.1733)


   

AKOS034138178

AKOS034138178

C21H25NO5 (371.1733)


   
   

2-Demethylcolchicein|2-Desmethylcolchicein|3-Demethyl-colchicein

2-Demethylcolchicein|2-Desmethylcolchicein|3-Demethyl-colchicein

C20H21NO6 (371.1369)


   

Mattogrossine

Mattogrossine

C21H25NO5 (371.1733)


   

Cryptopleurospermin|Cryptopleurospermine|[6-(2-dimethylamino-ethyl)-benzo[1,3]dioxol-5-yl]-(3-hydroxy-4-methoxy-phenyl)-ethanedione

Cryptopleurospermin|Cryptopleurospermine|[6-(2-dimethylamino-ethyl)-benzo[1,3]dioxol-5-yl]-(3-hydroxy-4-methoxy-phenyl)-ethanedione

C20H21NO6 (371.1369)


   

beta-Lumidemcolcine|beta-Lumidemecolcin|Lumidemecolcin

beta-Lumidemcolcine|beta-Lumidemecolcin|Lumidemecolcin

C21H25NO5 (371.1733)


   

SCHEMBL12714883

SCHEMBL12714883

C17H17N5O5 (371.123)


   
   
   

CHEMBL1668601

CHEMBL1668601

C20H21NO6 (371.1369)


   
   

7-Methoxy,2,3-epoxide-8-(3,3-Dimethylallyloxy)-N-methylflindersine

7-Methoxy,2,3-epoxide-8-(3,3-Dimethylallyloxy)-N-methylflindersine

C21H25NO5 (371.1733)


   

5,6-dimethoxy-2-(2,5,6-trimethoxyphenyl)-1h-quinolin-4-one

5,6-dimethoxy-2-(2,5,6-trimethoxyphenyl)-1h-quinolin-4-one

C20H21NO6 (371.1369)


   

2-Demethyl-N-deacetyl-N-formylcolchicine|2-Demethyl-N-formyl-N-desacetyl-colchicin

2-Demethyl-N-deacetyl-N-formylcolchicine|2-Demethyl-N-formyl-N-desacetyl-colchicin

C20H21NO6 (371.1369)


   
   

(-)-8-oxo-2,10-dihydroxy-3,9,11-trimethoxyberberine

(-)-8-oxo-2,10-dihydroxy-3,9,11-trimethoxyberberine

C20H21NO6 (371.1369)


   

CHEMBL1668602

CHEMBL1668602

C20H21NO6 (371.1369)


   

(-)-(S)-O-acetylevodine

(-)-(S)-O-acetylevodine

C20H21NO6 (371.1369)


   

Trigonostemine B

Trigonostemine B

C22H17N3O3 (371.127)


   

(+)-N-methoxycarbonyl-lindcarpine

(+)-N-methoxycarbonyl-lindcarpine

C20H21NO6 (371.1369)


   
   

SCHEMBL11639096

SCHEMBL11639096

C21H25NO5 (371.1733)


   

3-demethyl-N-methyl-(-)-demecolcine

3-demethyl-N-methyl-(-)-demecolcine

C21H25NO5 (371.1733)


   

7-O-(2-amino-2-deoxy-alpha-D-glucopyranosyl)-L-glycero-alpha-D-manno-heptopyranoside

7-O-(2-amino-2-deoxy-alpha-D-glucopyranosyl)-L-glycero-alpha-D-manno-heptopyranoside

C13H25NO11 (371.1428)


   

Floramultin|Merenderin|merobustinine

Floramultin|Merenderin|merobustinine

C21H25NO5 (371.1733)


   
   

(E)-N-[2-(4-hydroxyphenyl)-2-propoxyethyl] ferulamide

(E)-N-[2-(4-hydroxyphenyl)-2-propoxyethyl] ferulamide

C21H25NO5 (371.1733)


   
   

(+-)-Multifloramin|(+/-)-multifloramine|(RS)-Multifloramin|Multifloramin

(+-)-Multifloramin|(+/-)-multifloramine|(RS)-Multifloramin|Multifloramin

C21H25NO5 (371.1733)


   

N-(2-hydroxypropyl)lindcarpine

N-(2-hydroxypropyl)lindcarpine

C21H25NO5 (371.1733)


   
   

(-)-Androcymbine

(-)-Androcymbine

C21H25NO5 (371.1733)


   
   

(1,2,3-trimethoxy-9,10-methylenedioxynoraporphine)

(1,2,3-trimethoxy-9,10-methylenedioxynoraporphine)

C21H25NO5 (371.1733)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

N,N-dimethyl-2-oxo-3-(4,5,6,7-tetrahydro-1H-indol-2-ylmethylidene)-1H-indole-5-sulfonamide

N,N-dimethyl-2-oxo-3-(4,5,6,7-tetrahydro-1H-indol-2-ylmethylidene)-1H-indole-5-sulfonamide

C19H21N3O3S (371.1304)


   

7-O-acetylsalutaridinol

7-O-acetylsalutaridinol

C21H25NO5 (371.1733)


   

Epiberberine chloride

16,17-dimethoxy-5,7-dioxa-1-azoniapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),9,11,14,16,18-octaene;chloride

C20H18ClNO4 (371.0924)


Epiberberine chloride is an alkaloid isolated from Coptis chinensis, acts as a potent AChE and BChE inhibitor, and a non-competitive BACE1 inhibitor, with IC50s of 1.07, 6.03 and 8.55 μM, respectively. Epiberberine chloride has antioxidant activity, with peroxynitrite ONOO- scavenging effect (IC50, 16.83 μM), and may protect against Alzheimer disease[1]. Epiberberine chloride inhibits the early stage of differentiation of 3T3-L1 preadipocytes, downregulates the Raf/MEK1/2/ERK1/2 and AMPKα/Akt pathways[2]. Epiberberine has the potential effect in the research of diabetic disease[3]. Epiberberine chloride is an alkaloid isolated from Coptis chinensis, acts as a potent AChE and BChE inhibitor, and a non-competitive BACE1 inhibitor, with IC50s of 1.07, 6.03 and 8.55 μM, respectively. Epiberberine chloride has antioxidant activity, with peroxynitrite ONOO- scavenging effect (IC50, 16.83 μM), and may protect against Alzheimer disease[1]. Epiberberine chloride inhibits the early stage of differentiation of 3T3-L1 preadipocytes, downregulates the Raf/MEK1/2/ERK1/2 and AMPKα/Akt pathways[2]. Epiberberine has the potential effect in the research of diabetic disease[3].

   

Demecolcine

(7S)-7-(methylamino)-1,2,3,10-tetrakis(methyloxy)-6,7-dihydrobenzo[a]heptalen-9(5H)-one

C21H25NO5 (371.1733)


(-)-demecolcine is a secondary amino compound that is (S)-colchicine in which the N-acetyl group is replaced by an N-methyl group. Isolable from the autumn crocus, Colchicum autumnale, it is less toxic than colchicine and is used as an antineoplastic. It has a role as an antineoplastic agent and a microtubule-destabilising agent. It is an alkaloid and a secondary amino compound. Demecolcine is a natural product found in Colchicum arenarium, Colchicum crocifolium, and other organisms with data available. Demecolcine is a colchicine analog with potential antimitotic and antineoplastic activities. Demecolcine acid binds to the colchicine-binding site of tubulin, inhibiting its polymerization into microtubules, causing cell cycle arrest at metaphase and preventing cell division. An alkaloid isolated from Colchicum autumnale L. and used as an antineoplastic. L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01C - Plant alkaloids and other natural products > L01CC - Colchicine derivatives C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C273 - Antimitotic Agent D050258 - Mitosis Modulators > D050256 - Antimitotic Agents > D050257 - Tubulin Modulators D000970 - Antineoplastic Agents > D050256 - Antimitotic Agents ATC code: L01CC01 Origin: Plant; SubCategory_DNP: Isoquinoline alkaloids, Phenethylisoquinoline alkaloids, Colchicine alkaloids relative retention time with respect to 9-anthracene Carboxylic Acid is 0.681 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.679 Colcemid (Demecolcine) is a potent mitotic inhibitor with an IC50 value of 2.4 μM for inhibition of tubulin polymerization. Colcemid (Demecolcine) can interact with tubulin dimers to induce anti-mitotic action and inhibit microtubule growth. Colcemid (Demecolcine) can be used for inflammatory disorders and cancer research[1][2]. Colcemid (Demecolcine) is a potent mitotic inhibitor with an IC50 value of 2.4 μM for inhibition of tubulin polymerization. Colcemid (Demecolcine) can interact with tubulin dimers to induce anti-mitotic action and inhibit microtubule growth. Colcemid (Demecolcine) can be used for inflammatory disorders and cancer research[1][2].

   

Corynoxidine

(7S,13aS)-2,3,9,10-tetramethoxy-7-oxido-6,8,13,13a-tetrahydro-5H-isoquinolino[2,1-b]isoquinolin-7-ium

C21H25NO5 (371.1733)


Corynoxidine is a natural product found in Corydalis balansae, Corydalis speciosa, and Stephania rotunda with data available. (-)-Corynoxidine is an acetylcholinesterase inhibitor with an IC50 value of 89.0 μM, isolated from the aerial parts of Corydalis speciosa[1]. (-)-Corynoxidine exhibits antibacterial activities against Staphylococcus aureus and methicillin-resistant S. aureus strains in different degrees[2]. (-)-Corynoxidine is an acetylcholinesterase inhibitor with an IC50 value of 89.0 μM, isolated from the aerial parts of Corydalis speciosa[1]. (-)-Corynoxidine exhibits antibacterial activities against Staphylococcus aureus and methicillin-resistant S. aureus strains in different degrees[2].

   

Epicorynoxidine

(7R,13aS)-2,3,9,10-tetramethoxy-7-oxido-6,8,13,13a-tetrahydro-5H-isoquinolino[2,1-b]isoquinolin-7-ium

C21H25NO5 (371.1733)


Epicorynoxidine is a natural product found in Corydalis balansae and Stephania rotunda with data available.

   
   

C20H21NO6_6-Methoxy-2-methyl-3,4,6,8-tetrahydro-2H-spiro[indeno[4,5-d][1,3]dioxole-7,1-isoquinoline]-7,8-diol 2-oxide

NCGC00385471-01_C20H21NO6_6-Methoxy-2-methyl-3,4,6,8-tetrahydro-2H-spiro[indeno[4,5-d][1,3]dioxole-7,1-isoquinoline]-7,8-diol 2-oxide

C20H21NO6 (371.1369)


   

trazodone

trazodone

C19H22ClN5O (371.1513)


D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017367 - Selective Serotonin Reuptake Inhibitors D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent N - Nervous system > N06 - Psychoanaleptics > N06A - Antidepressants D049990 - Membrane Transport Modulators Trazodone (AF-1161 free base) is a serotonin receptor antagonist and reuptake inhibitor. Trazodone can be used for the research of major depressive disorder. Trazodone also has potential for sleep disorder research[1].

   

Berberine chloride

Berberine chloride

C20H18ClNO4 (371.0924)


   
   
   
   

Lycorine-diacetate

Lycorine-diacetate

C20H21NO6 (371.1369)


[Raw Data] CBA62_Lycorine-2Ac_pos_50eV.txt [Raw Data] CBA62_Lycorine-2Ac_pos_40eV.txt [Raw Data] CBA62_Lycorine-2Ac_pos_30eV.txt [Raw Data] CBA62_Lycorine-2Ac_pos_20eV.txt [Raw Data] CBA62_Lycorine-2Ac_pos_10eV.txt

   

Duguetine N-oxide

Duguetine N-oxide

C20H21NO6 (371.1369)


   

Duguetine ??-N-oxide

Duguetine ??-N-oxide

C20H21NO6 (371.1369)


   

2-Hydroxy-3-O-methylnaltrexone

2-Hydroxy-3-O-methylnaltrexone

C21H25NO5 (371.1733)


   
   
   
   
   
   
   
   
   
   
   
   
   

Diethylpropion (metabolite XI Glucuronide)

Diethylpropion (metabolite XI Glucuronide)

C17H25NO8 (371.158)


   
   
   
   
   
   
   
   
   
   
   
   
   

SU 6656

2,3-dihydro-N,N-dimethyl-2-oxo-3-[(4,5,6,7-tetrahydro-1H-indol-2-yl)methylene]-1H-indole-5-sulfonamide

C19H21N3O3S (371.1304)


SU6656 is a Src family kinases inhibitor with IC50s of 280, 20, 130, 170 nM for Src, Yes, Lyn, and Fyn, respectively. SU6656 inhibits FAK phosphorylation at Y576/577, Y925, Y861 sites. SU6656 also inhibits p-AKT.

   

JWH 018 N-pentanoic acid metabolite

5-(3-(1-naphthoyl)-1H-indol-1-yl)-pentanoic acid

C24H21NO3 (371.1521)


   

Phenylephrine 3-O-glucuronide

Phenylephrine 3-O-glucuronide

C17H25NO8 (371.158)


   

Alkaloid a4

17-methoxy-22-methyl-6,8,12-trioxa-22-azapentacyclo[11.9.0.0^{2,10}.0^{5,9}.0^{14,19}]docosa-2,4,9,14,16,18-hexaene-11,16-diol

C20H21NO6 (371.1369)


   

Rubemamine

(2E)-3-(3,4-dimethoxyphenyl)-N-[2-(3,4-dimethoxyphenyl)ethyl]prop-2-enamide

C21H25NO5 (371.1733)


   

Levobunolol sulfate

Levobunolol sulfate

C17H25NO6S (371.1403)


   

chelidonine monohydrate*

chelidonine monohydrate*

C20H21NO6 (371.1369)


   

camazepam

camazepam

C19H18ClN3O3 (371.1037)


N - Nervous system > N05 - Psycholeptics > N05B - Anxiolytics > N05BA - Benzodiazepine derivatives C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent

   

4-(5-hydroxy-4-oxo-2-phenylchromen-7-yl)oxybutyl nitrate

4-(5-hydroxy-4-oxo-2-phenylchromen-7-yl)oxybutyl nitrate

C19H17NO7 (371.1005)


   

3-hydroxy-4-[4-[5-(trifluoromethyl)pyridin-2-yl]oxyphenoxy]pentanoic acid

3-hydroxy-4-[4-[5-(trifluoromethyl)pyridin-2-yl]oxyphenoxy]pentanoic acid

C17H16F3NO5 (371.0981)


   

methyl 1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indole-3-acetate

methyl 1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indole-3-acetate

C20H18ClNO4 (371.0924)


   

(4-(3-CHLOROPHENYLAMINO)-1-METHYL-1H-IMIDAZO[4,5-C]PYRIDIN-7-YL)(MORPHOLINO)METHANONE

(4-(3-CHLOROPHENYLAMINO)-1-METHYL-1H-IMIDAZO[4,5-C]PYRIDIN-7-YL)(MORPHOLINO)METHANONE

C18H18ClN5O2 (371.1149)


   
   

3-[[2-[4-(2-phenylethynyl)phenoxy]acetyl]amino]benzoic acid

3-[[2-[4-(2-phenylethynyl)phenoxy]acetyl]amino]benzoic acid

C23H17NO4 (371.1158)


   

1-benzamido-4-(diazonioamino)-2,5-dimethoxybenzene,tetrafluoroborate

1-benzamido-4-(diazonioamino)-2,5-dimethoxybenzene,tetrafluoroborate

C15H14BF4N3O3 (371.1064)


   

ONO-RS-082

ONO-RS-082

C21H22ClNO3 (371.1288)


ONO-RS-082 is an inhibitor of phospholipase A (PLA)[1]. ONO-RS-082 inhibits PLA2 with the IC50 of 1.0 μM, but does not inhibit PLC even at 100 μM[2].

   

Boc-Tyr(Bzl)-OH

Boc-Tyr(Bzl)-OH

C21H25NO5 (371.1733)


   

Urea, N-[(2-chloro-7,8-dimethyl-3-quinolinyl)methyl]-N-(2-furanylmethyl)-N,N-dimethyl- (9CI)

Urea, N-[(2-chloro-7,8-dimethyl-3-quinolinyl)methyl]-N-(2-furanylmethyl)-N,N-dimethyl- (9CI)

C20H22ClN3O2 (371.14)


   

Urea, N-[(2-chloro-6,7-dimethyl-3-quinolinyl)methyl]-N-(2-furanylmethyl)-N,N-dimethyl- (9CI)

Urea, N-[(2-chloro-6,7-dimethyl-3-quinolinyl)methyl]-N-(2-furanylmethyl)-N,N-dimethyl- (9CI)

C20H22ClN3O2 (371.14)


   
   

4-(4,6-bis(2-hydroxyethoxy)-1,3,5-triazin-2-ylamino)benzenesulfonamide

4-(4,6-bis(2-hydroxyethoxy)-1,3,5-triazin-2-ylamino)benzenesulfonamide

C13H17N5O6S (371.09)


   
   

N6-(2-Phenylethyl)adenosine

N6-(2-Phenylethyl)adenosine

C18H21N5O4 (371.1593)


N6-(2-Phenylethyl)adenosine (N6-Phenethyladenosine), an adenosine derivative, is a potent adenosine receptors (AR) agonist with Ki values of 11.8 nM, 30.1 nM, 0.63 nM for rat A1AR, human A1AR and hA3AR, respectively[1]. N6-(2-Phenylethyl)adenosine (N6-Phenethyladenosine), an adenosine derivative, is a potent adenosine receptors (AR) agonist with Ki values of 11.8 nM, 30.1 nM, 0.63 nM for rat A1AR, human A1AR and hA3AR, respectively[1].

   

(R)-N-(1-(Naphthalen-1-yl)ethyl)-3-(3-(trifluoromethyl)phenyl)propanamide

(R)-N-(1-(Naphthalen-1-yl)ethyl)-3-(3-(trifluoromethyl)phenyl)propanamide

C22H20F3NO (371.1497)


   

Naratriptan Hydrochloride

Naratriptan Hydrochloride

C17H26ClN3O2S (371.1434)


D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists C78272 - Agent Affecting Nervous System > C47794 - Serotonin Agonist D002317 - Cardiovascular Agents > D014662 - Vasoconstrictor Agents Naratriptan hydrochloride is a selective 5-HT1 receptor subtype agonist and is a triptan drug that is used for the treatment of migraine headaches. Target: 5-HT1 Receptor Naratriptan is a triptan drug marketed by GlaxoSmithKline and is used for the treatment of migraine headaches. Naratriptan is available in 2.5 mg tablets. It is a selective 5-HT1 receptor subtype agonist. Naratriptan is used for the treatment of the acute migraine attacks and the symptoms of migraine, including severe, throbbing headaches that sometimes are accompanied by nausea and sensitivity to sound or light. The causes of migraine are not clearly understood; however, the efficacy of naratriptans and other triptans is believed to be due to their activity as 5HT (serotonin) agonists.A meta-analysis of 53 clinical trials has shown that all triptans are effective for treating migraine at marketed doses and that naratriptan, although less effective than sumatriptan and rizatriptan was more effective than placebo in reducing migraine symptoms at two hours and efficacy was demonstrated in almost two thirds of subjects after four hours of treatment.

   

N-(2,4-DIMETHYLPHENYL)-3-(PHOSPHONOOXY)-2-NAPHTHALENECARBOXAMIDE

N-(2,4-DIMETHYLPHENYL)-3-(PHOSPHONOOXY)-2-NAPHTHALENECARBOXAMIDE

C19H18NO5P (371.0923)


   

4-amino-5-chloro-N-[2-(diethylamino)ethyl]-2-methoxybenzamide,dihydrochloride

4-amino-5-chloro-N-[2-(diethylamino)ethyl]-2-methoxybenzamide,dihydrochloride

C14H24Cl3N3O2 (371.0934)


   
   

6-[[2-(1-METHYLETHYL)PHENYL]]SULFONYL-5-NITRO-8-QUINOLINAMINE

6-[[2-(1-METHYLETHYL)PHENYL]]SULFONYL-5-NITRO-8-QUINOLINAMINE

C18H17N3O4S (371.094)


   
   

Z-Glu(OBzl)-OH

Z-Glu(OBzl)-OH

C20H21NO6 (371.1369)


   

N-((4-NITROPHENYL)SULFONYL)-1-(TERT-BUTYLOXYCARBONYL)PIPERAZINE

N-((4-NITROPHENYL)SULFONYL)-1-(TERT-BUTYLOXYCARBONYL)PIPERAZINE

C15H21N3O6S (371.1151)


   

n6-benzoyl-8-hydroxy-2-deoxyadenosine

n6-benzoyl-8-hydroxy-2-deoxyadenosine

C17H17N5O5 (371.123)


   

Berberine (chloride hydrate)

Berberine (chloride hydrate)

C20H18ClNO4 (371.0924)


   

1-(4,4-diphenyl-3-butenyl)-3-piperidinecarboxylicacidhydrochloride;SKF89976AHCl

1-(4,4-diphenyl-3-butenyl)-3-piperidinecarboxylicacidhydrochloride;SKF89976AHCl

C22H26ClNO2 (371.1652)


SKF89976A hydrochloride is a selective GABA transporter (GAT-1) inhibitor with IC50s of 0.28 μM, 137.34 μM and 202.8 μM for GAT-1, GAT-2 and GAT-3 in CHO cells, respectively.

   

1-Methyl-2-(tributylstannyl)-1H-pyrrole

1-Methyl-2-(tributylstannyl)-1H-pyrrole

C17H33NSn (371.1635)


   

N-Cbz-D-glutamic acid α-benzyl ester

N-Cbz-D-glutamic acid α-benzyl ester

C20H21NO6 (371.1369)


   

Benzyl 2-fluoro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenylcarbamate

Benzyl 2-fluoro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenylcarbamate

C20H23BFNO4 (371.1704)


   

(E)-1-(4,8-dimethoxynaphthalen-1-yl)-N-(1-prop-2-enylbenzimidazol-2-yl)methanimine

(E)-1-(4,8-dimethoxynaphthalen-1-yl)-N-(1-prop-2-enylbenzimidazol-2-yl)methanimine

C23H21N3O2 (371.1634)


   

Ethyl 3-amino-2-{[(2-cyano-4-biphenylyl)methyl]amino}benzoate

Ethyl 3-amino-2-{[(2-cyano-4-biphenylyl)methyl]amino}benzoate

C23H21N3O2 (371.1634)


   

N6-Benzoyladenosine

N6-Benzoyladenosine

C17H17N5O5 (371.123)


   

5-O-BENZOYL-3-AZIDO-3-DEOXYTHYMIDINE

5-O-BENZOYL-3-AZIDO-3-DEOXYTHYMIDINE

C17H17N5O5 (371.123)


   
   

Olanexidine

Olanexidine

C17H27Cl2N5 (371.1643)


C254 - Anti-Infective Agent > C28394 - Topical Anti-Infective Agent D007004 - Hypoglycemic Agents > D001645 - Biguanides

   

1-Benzoyl-2,3-diphenylpyrrolidine-4-carboxylic acid

1-Benzoyl-2,3-diphenylpyrrolidine-4-carboxylic acid

C24H21NO3 (371.1521)


   

Ethyl 8-benzyl-5-hydroxy-2-(methylthio)-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidine-6-carboxylate

Ethyl 8-benzyl-5-hydroxy-2-(methylthio)-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidine-6-carboxylate

C18H17N3O4S (371.094)


   

Z-Tyr(tbu)-oh

Z-Tyr(tbu)-oh

C21H25NO5 (371.1733)


   

Methyl 4-{5-[bis(2-chloroethyl)amino]-1-methyl-1H-benzimidazol-2- yl}butanoate

Methyl 4-{5-[bis(2-chloroethyl)amino]-1-methyl-1H-benzimidazol-2- yl}butanoate

C17H23Cl2N3O2 (371.1167)


   

Tubastatin A HCl

Tubastatin A HCl

C20H22ClN3O2 (371.14)


   

SEA-0400

2-(4-((2,5-Difluorobenzyl)oxy)phenoxy)-5-ethoxyaniline

C21H19F2NO3 (371.1333)


   

Azaribine

6-AZAURIDINE 2,3,5-TRIACETATE

C14H17N3O9 (371.0965)


C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C272 - Antimetabolite C471 - Enzyme Inhibitor > C2170 - Orotidylate Decarboxylase Inhibitor D003879 - Dermatologic Agents Azaribine (2',3',5'-Tri-O-acetyl-6-azauridine) is a potent orotidine monophosphate decarboxylase (OMPD) inhibitor. Azaribine is an antiviral inhibitor of several RNA viruses and inhibits viral genome replication and gene transcription. Azaribine shows broad-spectrum antiviral activity (EC50=3.80?nM-1.73?μM against influenza A and B viruses; EC50=1.62 μM against ZIKV Paraiba). Azaribine, a triacetate salt of Azauridine, has the potential for psoriasis research[1][2].

   

Boc-D-Tyr(Bzl)-OH

Boc-D-Tyr(Bzl)-OH

C21H25NO5 (371.1733)


   

N-(1-(NAPHTHALEN-1-YL)ETHYL)-3-(3-(TRIFLUOROMETHYL)PHENYL)PROPANAMIDE

N-(1-(NAPHTHALEN-1-YL)ETHYL)-3-(3-(TRIFLUOROMETHYL)PHENYL)PROPANAMIDE

C22H20F3NO (371.1497)


   

Z-D-Glu(OBzl)-OH

Z-D-Glu(OBzl)-OH

C20H21NO6 (371.1369)


   

Z-Tyr-OtBu.H2O

Z-Tyr-OtBu.H2O

C21H25NO5 (371.1733)


   

Fmoc-cys(et)-oh

Fmoc-cys(et)-oh

C20H21NO4S (371.1191)


   

7-HYDROXY-8-((2-METHOXYPHENYL)DIAZENYL)-N,N,N-TRIMETHYLNAPHTHALEN-2-AMINIUM CHLORIDE

7-HYDROXY-8-((2-METHOXYPHENYL)DIAZENYL)-N,N,N-TRIMETHYLNAPHTHALEN-2-AMINIUM CHLORIDE

C20H22ClN3O2 (371.14)


   

Xanomeline oxalate

Xanomeline oxalate

C16H25N3O5S (371.1515)


Xanomeline oxalate (LY246708 oxalate) is a potent and selective muscarinic receptor agonist (SMRA) and stimulates phosphoinositide hydrolysis in vivo. Xanomeline oxalate can be used for the research of Alzheimer’s disease[1].

   
   

N-boc-O-benzyl-D-tyrosine

N-boc-O-benzyl-D-tyrosine

C21H25NO5 (371.1733)


   

(S)-4-tert-butoxycarbonyl-2-p-toluenesulfonyloxymethylmorpholine

(S)-4-tert-butoxycarbonyl-2-p-toluenesulfonyloxymethylmorpholine

C17H25NO6S (371.1403)


   
   

N-(4-(naphthalen-1-yl)phenyl)-[1,1-biphenyl]-4-amine

N-(4-(naphthalen-1-yl)phenyl)-[1,1-biphenyl]-4-amine

C28H21N (371.1674)


   

1,2,3,4-Tetraphenyl-1H-pyrrole

1,2,3,4-Tetraphenyl-1H-pyrrole

C28H21N (371.1674)


   

3-QUINOLINECARBOXYLIC ACID, 4-CHLORO-6-METHOXY-7-(PHENYLMETHOXY)-, ETHYL ESTER

3-QUINOLINECARBOXYLIC ACID, 4-CHLORO-6-METHOXY-7-(PHENYLMETHOXY)-, ETHYL ESTER

C20H18ClNO4 (371.0924)


   
   

2-[(2-Acetamido-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl benzoate

2-[(2-Acetamido-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl benzoate

C17H17N5O5 (371.123)


   
   

tert-butyl 4-broMo-2-fluorobenzyl(cyclopentyl)carbaMate

tert-butyl 4-broMo-2-fluorobenzyl(cyclopentyl)carbaMate

C17H23BrFNO2 (371.0896)


   

tert-butyl 4-broMo-3-fluorobenzyl(cyclopentyl)carbaMate

tert-butyl 4-broMo-3-fluorobenzyl(cyclopentyl)carbaMate

C17H23BrFNO2 (371.0896)


   

N-[4-(2-Naphthalenyl)phenyl]-[1,1-biphneyl]-4-amine

N-[4-(2-Naphthalenyl)phenyl]-[1,1-biphneyl]-4-amine

C28H21N (371.1674)


   

N,N-diMethyl-4-((E)-4-((E)-(4-nitrobenzylidene)aMino)styryl)aniline

N,N-diMethyl-4-((E)-4-((E)-(4-nitrobenzylidene)aMino)styryl)aniline

C23H21N3O2 (371.1634)


   

Benzyl 2-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenylcarbamate

Benzyl 2-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenylcarbamate

C20H23BFNO4 (371.1704)


   

4-(Benzyloxycarbonylamino)-2-fluorophenylboronic acid, pinacol ester

4-(Benzyloxycarbonylamino)-2-fluorophenylboronic acid, pinacol ester

C20H23BFNO4 (371.1704)


   

2-Oxazolidinone,3-[(5S)-5-(4-fluorophenyl)-5-hydroxy-1-oxopentyl]-4-(phenylmethyl)-,(4S)-

2-Oxazolidinone,3-[(5S)-5-(4-fluorophenyl)-5-hydroxy-1-oxopentyl]-4-(phenylmethyl)-,(4S)-

C21H22FNO4 (371.1533)


   
   

1-amino-4-[[4-[(dimethylamino)methyl]phenyl]amino]anthraquinone

1-amino-4-[[4-[(dimethylamino)methyl]phenyl]amino]anthraquinone

C23H21N3O2 (371.1634)


   

6-methylheptoxycarbonylmethanethiolate: trimethyltin

6-methylheptoxycarbonylmethanethiolate: trimethyltin

C13H31O2SSn (371.1067)


   

Incyclinide

Incyclinide

C19H17NO7 (371.1005)


C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C1970 - Matrix Metalloproteinase Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor

   

1,5-Naphthyridine-3-carboxamide, 7-((4-fluorophenyl)methyl)-1,2-dihydro-4-hydroxy-N-(2-hydroxyethyl)-1-methyl-2-oxo-

1,5-Naphthyridine-3-carboxamide, 7-((4-fluorophenyl)methyl)-1,2-dihydro-4-hydroxy-N-(2-hydroxyethyl)-1-methyl-2-oxo-

C19H18FN3O4 (371.1281)


   

SU6656

(3z)-N,N-Dimethyl-2-Oxo-3-(4,5,6,7-Tetrahydro-1h-Indol-2-Ylmethylidene)-2,3-Dihydro-1h-Indole-5-Sulfonamide

C19H21N3O3S (371.1304)


SU6656 is a Src family kinases inhibitor with IC50s of 280, 20, 130, 170 nM for Src, Yes, Lyn, and Fyn, respectively. SU6656 inhibits FAK phosphorylation at Y576/577, Y925, Y861 sites. SU6656 also inhibits p-AKT.

   

4-[8-(3-nitrophenyl)-1,7-naphthyridin-6-yl]benzoic Acid

4-[8-(3-nitrophenyl)-1,7-naphthyridin-6-yl]benzoic Acid

C21H13N3O4 (371.0906)


   

[5-Amino-1-(4-fluorophenyl)-1H-pyrazol-4-YL](3-{[(2R)-2,3-dihydroxypropyl]oxy}phenyl)methanone

[5-Amino-1-(4-fluorophenyl)-1H-pyrazol-4-YL](3-{[(2R)-2,3-dihydroxypropyl]oxy}phenyl)methanone

C19H18FN3O4 (371.1281)


   

Ampicillin sodium

Ampicillin sodium

C16H18N3NaO4S (371.0916)


D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic

   

Triaminophenyl phosphate

Triaminophenyl phosphate

C18H18N3O4P (371.1035)


   

1-[1-oxo-2-[(4-oxo-2,3-dihydro-1H-cyclopenta[c][1]benzopyran-7-yl)oxy]ethyl]-4-piperidinecarboxylic acid

1-[1-oxo-2-[(4-oxo-2,3-dihydro-1H-cyclopenta[c][1]benzopyran-7-yl)oxy]ethyl]-4-piperidinecarboxylic acid

C20H21NO6 (371.1369)


   

N-cyclohexyl-2-[[6-(4-ethoxyphenyl)-3-pyridazinyl]thio]acetamide

N-cyclohexyl-2-[[6-(4-ethoxyphenyl)-3-pyridazinyl]thio]acetamide

C20H25N3O2S (371.1667)


   

N-[4-[(1,2-dimethyl-5-indolyl)methylsulfamoyl]phenyl]acetamide

N-[4-[(1,2-dimethyl-5-indolyl)methylsulfamoyl]phenyl]acetamide

C19H21N3O3S (371.1304)


   
   

3,5-Pyridinedicarboxylic acid, 4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydro-2,6-dimethyl-, methyl 1-methylethyl ester, (4S)-

3,5-Pyridinedicarboxylic acid, 4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydro-2,6-dimethyl-, methyl 1-methylethyl ester, (4S)-

C19H21N3O5 (371.1481)


   

(R)-N-(3-Indol-1-YL-2-methyl-propyl)-4-sulfamoyl-benzamide

(R)-N-(3-Indol-1-YL-2-methyl-propyl)-4-sulfamoyl-benzamide

C19H21N3O3S (371.1304)


   

(S)-N-(3-Indol-1-YL-2-methyl-propyl)-4-sulfamoyl-benzamide

(S)-N-(3-Indol-1-YL-2-methyl-propyl)-4-sulfamoyl-benzamide

C19H21N3O3S (371.1304)


   

2-(Cycloheptylmethyl)-1,1-dioxido-1-benzothiophen-6-yl sulfamate

2-(Cycloheptylmethyl)-1,1-dioxido-1-benzothiophen-6-yl sulfamate

C16H21NO5S2 (371.0861)


   

N-[2-(1H-Indol-5-YL)-butyl]-4-sulfamoyl-benzamide

N-[2-(1H-Indol-5-YL)-butyl]-4-sulfamoyl-benzamide

C19H21N3O3S (371.1304)


   

Baricitinib

Baricitinib

C16H17N7O2S (371.1164)


L - Antineoplastic and immunomodulating agents > L04 - Immunosuppressants > L04A - Immunosuppressants > L04AA - Selective immunosuppressants C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor COVID info from Guide to PHARMACOLOGY, clinicaltrial, clinicaltrials, clinical trial, clinical trials, DrugBank C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C172200 - JAK Inhibitor Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

Lenperone

Lenperone

C22H23F2NO2 (371.1697)


C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent

   

Darodipine

Darodipine

C19H21N3O5 (371.1481)


C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker

   

(-)-Dehydrodiconiferyl acid

(-)-Dehydrodiconiferyl acid

C20H19O7- (371.1131)


   

(+)-Dehydrodiconiferyl acid

(+)-Dehydrodiconiferyl acid

C20H19O7- (371.1131)


   

Tyrosine-betaxanthin

Tyrosine-betaxanthin

C18H15N2O7-3 (371.0879)


   

Dehydrodiconiferyl acid

Dehydrodiconiferyl acid

C20H19O7- (371.1131)


   

(2S)-2-[[2-[(1R,2S)-3-oxo-2-[(Z)-5-oxopent-2-enyl]cyclopentyl]acetyl]amino]-3-phenylpropanoic acid

(2S)-2-[[2-[(1R,2S)-3-oxo-2-[(Z)-5-oxopent-2-enyl]cyclopentyl]acetyl]amino]-3-phenylpropanoic acid

C21H25NO5 (371.1733)


   

Hydroxydesmethylpiperine sulfate

Hydroxydesmethylpiperine sulfate

C16H21NO7S (371.1039)


   
   

2-[1-[2-Oxo-2-[(4-thiophen-2-ylphenyl)methylamino]ethyl]cyclohexyl]acetic acid

2-[1-[2-Oxo-2-[(4-thiophen-2-ylphenyl)methylamino]ethyl]cyclohexyl]acetic acid

C21H25NO3S (371.1555)


   
   

(S)-averantin(1-)

(S)-averantin(1-)

C20H19O7- (371.1131)


A phenolate anion obtained by deprotonation of the 2-hydroxy group of (S)-averantin. It is the major microspecies at pH 7.3 (according to Marvin v 6.2.0.).

   

(+)-N-(methoxycarbonyl)-N-norboldine

(+)-N-(methoxycarbonyl)-N-norboldine

C20H21NO6 (371.1369)


An aporphine alkaloid that is laurolistine with a N-methoxycarbonyl group. Isolated from the aerial parts of Litsea cubeba, it exhibits antimicrobial activities.

   

4-hydroxy-1-(3-methylbutyl)-N-(5-methyl-1,3-thiazol-2-yl)-2-oxo-1,2-dihydroquinoline-3-carboxamide

4-hydroxy-1-(3-methylbutyl)-N-(5-methyl-1,3-thiazol-2-yl)-2-oxo-1,2-dihydroquinoline-3-carboxamide

C19H21N3O3S (371.1304)


   

1-[2-(2-Amino-3-cyano-1-pyrrolo[3,2-b]quinoxalinyl)ethyl]-3-phenylurea

1-[2-(2-Amino-3-cyano-1-pyrrolo[3,2-b]quinoxalinyl)ethyl]-3-phenylurea

C20H17N7O (371.1495)


   

5-[[2,3-Dihydro-1,4-benzodioxin-3-yl(oxo)methyl]amino]benzene-1,3-dicarboxylic acid dimethyl ester

5-[[2,3-Dihydro-1,4-benzodioxin-3-yl(oxo)methyl]amino]benzene-1,3-dicarboxylic acid dimethyl ester

C19H17NO7 (371.1005)


   

(5Z)-3-hexyl-5-[(5-phenyl-1H-pyrazol-4-yl)methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one

(5Z)-3-hexyl-5-[(5-phenyl-1H-pyrazol-4-yl)methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one

C19H21N3OS2 (371.1126)


   

4-(2,3-dihydro-1,4-benzodioxin-6-yl)-3-(3,4-dimethoxyphenyl)-1H-1,2,4-triazole-5-thione

4-(2,3-dihydro-1,4-benzodioxin-6-yl)-3-(3,4-dimethoxyphenyl)-1H-1,2,4-triazole-5-thione

C18H17N3O4S (371.094)


   

1-[[1-Oxo-3-(4-propan-2-yloxyphenyl)propyl]amino]-3-(phenylmethyl)thiourea

1-[[1-Oxo-3-(4-propan-2-yloxyphenyl)propyl]amino]-3-(phenylmethyl)thiourea

C20H25N3O2S (371.1667)


   

3-{[5-(4-hydroxyphenyl)-1,3,4-oxadiazol-2-yl]sulfanyl}-N-(2-methoxyphenyl)propanamide

3-{[5-(4-hydroxyphenyl)-1,3,4-oxadiazol-2-yl]sulfanyl}-N-(2-methoxyphenyl)propanamide

C18H17N3O4S (371.094)


   

5-(2,3-Dihydroindol-1-ylsulfonyl)-1,3-diethyl-2-benzimidazolone

5-(2,3-Dihydroindol-1-ylsulfonyl)-1,3-diethyl-2-benzimidazolone

C19H21N3O3S (371.1304)


   

[4-[[4-(Methylthio)phenyl]methyl]-1-piperazinyl]-(4-nitrophenyl)methanone

[4-[[4-(Methylthio)phenyl]methyl]-1-piperazinyl]-(4-nitrophenyl)methanone

C19H21N3O3S (371.1304)


   

N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-[(6-methoxy-1H-benzimidazol-2-yl)thio]acetamide

N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-[(6-methoxy-1H-benzimidazol-2-yl)thio]acetamide

C18H17N3O4S (371.094)


   

3-Methyl-1-phenyl-5-thieno[2,3-c]pyrazolecarboxylic acid [2-(butylamino)-2-oxoethyl] ester

3-Methyl-1-phenyl-5-thieno[2,3-c]pyrazolecarboxylic acid [2-(butylamino)-2-oxoethyl] ester

C19H21N3O3S (371.1304)


   

N-(1,3-benzothiazol-2-yl)-2-[(E)-(3,4-dimethoxyphenyl)methylideneamino]oxyacetamide

N-(1,3-benzothiazol-2-yl)-2-[(E)-(3,4-dimethoxyphenyl)methylideneamino]oxyacetamide

C18H17N3O4S (371.094)


   

2-[4-[(4-chlorophenyl)methyl]piperazin-1-yl]-N-[(E)-pyridin-4-ylmethylideneamino]acetamide

2-[4-[(4-chlorophenyl)methyl]piperazin-1-yl]-N-[(E)-pyridin-4-ylmethylideneamino]acetamide

C19H22ClN5O (371.1513)


   

2-[3-(4-Methoxyphenyl)-1-benzo[f]quinolinyl]acetic acid ethyl ester

2-[3-(4-Methoxyphenyl)-1-benzo[f]quinolinyl]acetic acid ethyl ester

C24H21NO3 (371.1521)


   

2-(2,5-Difluorophenyl)-5-methyl-4-[[4-(2-pyrazinyl)-1-piperazinyl]methyl]oxazole

2-(2,5-Difluorophenyl)-5-methyl-4-[[4-(2-pyrazinyl)-1-piperazinyl]methyl]oxazole

C19H19F2N5O (371.1558)


   

4-methyl-N-(3-methylbutyl)-5-(5-methyl-3-phenyl-4H-isoxazol-5-yl)-2-thiazolecarboxamide

4-methyl-N-(3-methylbutyl)-5-(5-methyl-3-phenyl-4H-isoxazol-5-yl)-2-thiazolecarboxamide

C20H25N3O2S (371.1667)


   

1-[4-(3-Hydroxy-2-methoxyphenyl)-4-(3-hydroxy-4-methoxyphenyl)-1-piperidinyl]ethanone

1-[4-(3-Hydroxy-2-methoxyphenyl)-4-(3-hydroxy-4-methoxyphenyl)-1-piperidinyl]ethanone

C21H25NO5 (371.1733)


   

Herqueinone(1-)

Herqueinone(1-)

C20H19O7- (371.1131)


   

N-[(8-methoxy-5-nitro-7-quinolinyl)-thiophen-2-ylmethyl]propanamide

N-[(8-methoxy-5-nitro-7-quinolinyl)-thiophen-2-ylmethyl]propanamide

C18H17N3O4S (371.094)


   

4-(2,1,3-benzoxadiazol-4-yl)-2,6-dimethyl-3,4-dihydropyridine-3,5-dicarboxylic acid O3-methyl ester O5-propan-2-yl ester

4-(2,1,3-benzoxadiazol-4-yl)-2,6-dimethyl-3,4-dihydropyridine-3,5-dicarboxylic acid O3-methyl ester O5-propan-2-yl ester

C19H21N3O5 (371.1481)


   

(4aS,5aR,12aS)-10,12a-dihydroxy-1,3,11,12-tetraoxo-4,4a,5,5a,6,11a-hexahydrotetracene-2-carboxamide

(4aS,5aR,12aS)-10,12a-dihydroxy-1,3,11,12-tetraoxo-4,4a,5,5a,6,11a-hexahydrotetracene-2-carboxamide

C19H17NO7 (371.1005)


   

5-(dimethylamino)-N-[4-(hydroxyamino)benzyl]naphthalene-1-sulfonamide

5-(dimethylamino)-N-[4-(hydroxyamino)benzyl]naphthalene-1-sulfonamide

C19H21N3O3S (371.1304)


   
   
   
   
   
   
   
   

1-(2-chlorophenyl)-N-[(1-cyclopentyl-5-tetrazolyl)methyl]-N-(2-furanylmethyl)methanamine

1-(2-chlorophenyl)-N-[(1-cyclopentyl-5-tetrazolyl)methyl]-N-(2-furanylmethyl)methanamine

C19H22ClN5O (371.1513)


   

2-[(2S,3R,6R)-2-(hydroxymethyl)-3-[(4-methoxyphenyl)sulfonylamino]-3,6-dihydro-2H-pyran-6-yl]acetic acid methyl ester

2-[(2S,3R,6R)-2-(hydroxymethyl)-3-[(4-methoxyphenyl)sulfonylamino]-3,6-dihydro-2H-pyran-6-yl]acetic acid methyl ester

C16H21NO7S (371.1039)


   

methyl 2-[(1R,3R,4aS,9aR)-1-(hydroxymethyl)-6-(methanesulfonamido)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]acetate

methyl 2-[(1R,3R,4aS,9aR)-1-(hydroxymethyl)-6-(methanesulfonamido)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]acetate

C16H21NO7S (371.1039)


   

(2R,3S,4R)-3-[4-(2-cyclopropylethynyl)phenyl]-4-(hydroxymethyl)-1-[1-oxo-2-(2-pyridinyl)ethyl]-2-azetidinecarbonitrile

(2R,3S,4R)-3-[4-(2-cyclopropylethynyl)phenyl]-4-(hydroxymethyl)-1-[1-oxo-2-(2-pyridinyl)ethyl]-2-azetidinecarbonitrile

C23H21N3O2 (371.1634)


   

methyl 2-[(1S,3S,4aR,9aS)-1-(hydroxymethyl)-6-(methanesulfonamido)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]acetate

methyl 2-[(1S,3S,4aR,9aS)-1-(hydroxymethyl)-6-(methanesulfonamido)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]acetate

C16H21NO7S (371.1039)


   

methyl 2-[(1R,3S,4aS,9aR)-1-(hydroxymethyl)-6-(methanesulfonamido)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]acetate

methyl 2-[(1R,3S,4aS,9aR)-1-(hydroxymethyl)-6-(methanesulfonamido)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]acetate

C16H21NO7S (371.1039)


   

(2R,3R,4S)-3-[4-(2-cyclopropylethynyl)phenyl]-4-(hydroxymethyl)-1-[1-oxo-2-(2-pyridinyl)ethyl]-2-azetidinecarbonitrile

(2R,3R,4S)-3-[4-(2-cyclopropylethynyl)phenyl]-4-(hydroxymethyl)-1-[1-oxo-2-(2-pyridinyl)ethyl]-2-azetidinecarbonitrile

C23H21N3O2 (371.1634)


   

(2S,3R,4S)-3-[4-(2-cyclopropylethynyl)phenyl]-4-(hydroxymethyl)-1-[1-oxo-2-(2-pyridinyl)ethyl]-2-azetidinecarbonitrile

(2S,3R,4S)-3-[4-(2-cyclopropylethynyl)phenyl]-4-(hydroxymethyl)-1-[1-oxo-2-(2-pyridinyl)ethyl]-2-azetidinecarbonitrile

C23H21N3O2 (371.1634)


   

(2S,3R,4R)-3-[4-(2-cyclopropylethynyl)phenyl]-4-(hydroxymethyl)-1-(2-pyridin-2-ylacetyl)azetidine-2-carbonitrile

(2S,3R,4R)-3-[4-(2-cyclopropylethynyl)phenyl]-4-(hydroxymethyl)-1-(2-pyridin-2-ylacetyl)azetidine-2-carbonitrile

C23H21N3O2 (371.1634)


   

(2R,3S)-8-bromo-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

(2R,3S)-8-bromo-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

C15H22BrN3O3 (371.0844)


   

(2R,3R)-8-bromo-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

(2R,3R)-8-bromo-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

C15H22BrN3O3 (371.0844)


   

(2S,3R)-8-bromo-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

(2S,3R)-8-bromo-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

C15H22BrN3O3 (371.0844)


   

2-[(2S,5R,6S)-5-(ethylsulfonylamino)-6-(hydroxymethyl)-2-oxanyl]-N-(2-pyridinylmethyl)acetamide

2-[(2S,5R,6S)-5-(ethylsulfonylamino)-6-(hydroxymethyl)-2-oxanyl]-N-(2-pyridinylmethyl)acetamide

C16H25N3O5S (371.1515)


   

2-[(2R,3S,6R)-2-(hydroxymethyl)-3-[(4-methoxyphenyl)sulfonylamino]-3,6-dihydro-2H-pyran-6-yl]acetic acid methyl ester

2-[(2R,3S,6R)-2-(hydroxymethyl)-3-[(4-methoxyphenyl)sulfonylamino]-3,6-dihydro-2H-pyran-6-yl]acetic acid methyl ester

C16H21NO7S (371.1039)


   

2-[(2R,3R,6S)-2-(hydroxymethyl)-3-[(4-methoxyphenyl)sulfonylamino]-3,6-dihydro-2H-pyran-6-yl]acetic acid methyl ester

2-[(2R,3R,6S)-2-(hydroxymethyl)-3-[(4-methoxyphenyl)sulfonylamino]-3,6-dihydro-2H-pyran-6-yl]acetic acid methyl ester

C16H21NO7S (371.1039)


   

2-[(1S,3R,4aR,9aS)-1-(hydroxymethyl)-6-(methanesulfonamido)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]acetic acid methyl ester

2-[(1S,3R,4aR,9aS)-1-(hydroxymethyl)-6-(methanesulfonamido)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]acetic acid methyl ester

C16H21NO7S (371.1039)


   

(2S,3S,3aR,9bR)-7-(4-fluorophenyl)-3-(hydroxymethyl)-N,N-dimethyl-6-oxo-1,2,3,3a,4,9b-hexahydropyrrolo[2,3-a]indolizine-2-carboxamide

(2S,3S,3aR,9bR)-7-(4-fluorophenyl)-3-(hydroxymethyl)-N,N-dimethyl-6-oxo-1,2,3,3a,4,9b-hexahydropyrrolo[2,3-a]indolizine-2-carboxamide

C20H22FN3O3 (371.1645)


   

(2R,3S)-8-bromo-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

(2R,3S)-8-bromo-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

C15H22BrN3O3 (371.0844)


   

(2S,3R)-8-bromo-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

(2S,3R)-8-bromo-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

C15H22BrN3O3 (371.0844)


   

(2S,3S)-8-bromo-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

(2S,3S)-8-bromo-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

C15H22BrN3O3 (371.0844)


   

(2R,3R)-8-bromo-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

(2R,3R)-8-bromo-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

C15H22BrN3O3 (371.0844)


   

(2S,3S)-8-bromo-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

(2S,3S)-8-bromo-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

C15H22BrN3O3 (371.0844)


   

2-[(2S,5S,6R)-5-(ethylsulfonylamino)-6-(hydroxymethyl)-2-oxanyl]-N-(2-pyridinylmethyl)acetamide

2-[(2S,5S,6R)-5-(ethylsulfonylamino)-6-(hydroxymethyl)-2-oxanyl]-N-(2-pyridinylmethyl)acetamide

C16H25N3O5S (371.1515)


   

2-[(2R,3S,6S)-2-(hydroxymethyl)-3-[(4-methoxyphenyl)sulfonylamino]-3,6-dihydro-2H-pyran-6-yl]acetic acid methyl ester

2-[(2R,3S,6S)-2-(hydroxymethyl)-3-[(4-methoxyphenyl)sulfonylamino]-3,6-dihydro-2H-pyran-6-yl]acetic acid methyl ester

C16H21NO7S (371.1039)


   

2-[(2S,3R,6S)-2-(hydroxymethyl)-3-[(4-methoxyphenyl)sulfonylamino]-3,6-dihydro-2H-pyran-6-yl]acetic acid methyl ester

2-[(2S,3R,6S)-2-(hydroxymethyl)-3-[(4-methoxyphenyl)sulfonylamino]-3,6-dihydro-2H-pyran-6-yl]acetic acid methyl ester

C16H21NO7S (371.1039)


   

2-[(2S,3S,6R)-2-(hydroxymethyl)-3-[(4-methoxyphenyl)sulfonylamino]-3,6-dihydro-2H-pyran-6-yl]acetic acid methyl ester

2-[(2S,3S,6R)-2-(hydroxymethyl)-3-[(4-methoxyphenyl)sulfonylamino]-3,6-dihydro-2H-pyran-6-yl]acetic acid methyl ester

C16H21NO7S (371.1039)


   

2-[(2S,3S,6S)-2-(hydroxymethyl)-3-[(4-methoxyphenyl)sulfonylamino]-3,6-dihydro-2H-pyran-6-yl]acetic acid methyl ester

2-[(2S,3S,6S)-2-(hydroxymethyl)-3-[(4-methoxyphenyl)sulfonylamino]-3,6-dihydro-2H-pyran-6-yl]acetic acid methyl ester

C16H21NO7S (371.1039)


   

2-[(2R,3R,6R)-2-(hydroxymethyl)-3-[(4-methoxyphenyl)sulfonylamino]-3,6-dihydro-2H-pyran-6-yl]acetic acid methyl ester

2-[(2R,3R,6R)-2-(hydroxymethyl)-3-[(4-methoxyphenyl)sulfonylamino]-3,6-dihydro-2H-pyran-6-yl]acetic acid methyl ester

C16H21NO7S (371.1039)


   

2-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-6-(methanesulfonamido)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]acetic acid methyl ester

2-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-6-(methanesulfonamido)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]acetic acid methyl ester

C16H21NO7S (371.1039)


   

2-[(1R,3S,4aR,9aS)-1-(hydroxymethyl)-6-(methanesulfonamido)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]acetic acid methyl ester

2-[(1R,3S,4aR,9aS)-1-(hydroxymethyl)-6-(methanesulfonamido)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]acetic acid methyl ester

C16H21NO7S (371.1039)


   

2-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-6-(methanesulfonamido)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]acetic acid methyl ester

2-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-6-(methanesulfonamido)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]acetic acid methyl ester

C16H21NO7S (371.1039)


   

(2R,3R,3aS,9bS)-7-(4-fluorophenyl)-3-(hydroxymethyl)-N,N-dimethyl-6-oxo-1,2,3,3a,4,9b-hexahydropyrrolo[2,3-a]indolizine-2-carboxamide

(2R,3R,3aS,9bS)-7-(4-fluorophenyl)-3-(hydroxymethyl)-N,N-dimethyl-6-oxo-1,2,3,3a,4,9b-hexahydropyrrolo[2,3-a]indolizine-2-carboxamide

C20H22FN3O3 (371.1645)


   

hydron;N-methyl-2-[3-(1-methylpiperidin-4-yl)-1H-indol-5-yl]ethanesulfonamide;chloride

hydron;N-methyl-2-[3-(1-methylpiperidin-4-yl)-1H-indol-5-yl]ethanesulfonamide;chloride

C17H26ClN3O2S (371.1434)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

(2E)-2-[(E)-benzylidenehydrazinylidene]-5,5-diphenyl-1,3-thiazolidin-4-one

(2E)-2-[(E)-benzylidenehydrazinylidene]-5,5-diphenyl-1,3-thiazolidin-4-one

C22H17N3OS (371.1092)


   

1,2-Diacetoxylycorine

1,2-Diacetoxylycorine

C20H21NO6 (371.1369)


   

(4S)-2-(1,3-benzothiazol-2-yl)-5-methyl-4-(naphthalen-1-ylmethyl)-4H-pyrazol-3-one

(4S)-2-(1,3-benzothiazol-2-yl)-5-methyl-4-(naphthalen-1-ylmethyl)-4H-pyrazol-3-one

C22H17N3OS (371.1092)


   

2-Amino-3-[2,3-di(propanoyloxy)propoxy-hydroxyphosphoryl]oxypropanoic acid

2-Amino-3-[2,3-di(propanoyloxy)propoxy-hydroxyphosphoryl]oxypropanoic acid

C12H22NO10P (371.0981)


   

2-Amino-3-[(3-heptanoyloxy-2-hydroxypropoxy)-hydroxyphosphoryl]oxypropanoic acid

2-Amino-3-[(3-heptanoyloxy-2-hydroxypropoxy)-hydroxyphosphoryl]oxypropanoic acid

C13H26NO9P (371.1345)


   

(11S,12S,13S)-16,17-dimethoxy-11-methyl-11-oxido-3,5-dioxa-11-azoniapentacyclo[10.7.1.02,6.08,20.014,19]icosa-1(20),2(6),7,14,16,18-hexaen-13-ol

(11S,12S,13S)-16,17-dimethoxy-11-methyl-11-oxido-3,5-dioxa-11-azoniapentacyclo[10.7.1.02,6.08,20.014,19]icosa-1(20),2(6),7,14,16,18-hexaen-13-ol

C20H21NO6 (371.1369)


   
   
   
   

3-[(3-Acetyloxy-2-butanoyloxypropoxy)-hydroxyphosphoryl]oxy-2-aminopropanoic acid

3-[(3-Acetyloxy-2-butanoyloxypropoxy)-hydroxyphosphoryl]oxy-2-aminopropanoic acid

C12H22NO10P (371.0981)


   

(11R,12S,13S)-16,17-dimethoxy-11-methyl-11-oxido-3,5-dioxa-11-azoniapentacyclo[10.7.1.02,6.08,20.014,19]icosa-1(20),2(6),7,14,16,18-hexaen-13-ol

(11R,12S,13S)-16,17-dimethoxy-11-methyl-11-oxido-3,5-dioxa-11-azoniapentacyclo[10.7.1.02,6.08,20.014,19]icosa-1(20),2(6),7,14,16,18-hexaen-13-ol

C20H21NO6 (371.1369)


   

9,11-Diphenylbenzo(E)pyrimido(4,5-B)indole

9,11-Diphenylbenzo(E)pyrimido(4,5-B)indole

C26H17N3 (371.1422)


   

Berberinum

16,17-dimethoxy-5,7-dioxa-13lambda5-azapentacyclo[11.8.0.0^{2,10}.0^{4,8}.0^{15,20}]henicosa-1(21),2(10),3,8,13,15(20),16,18-octaen-13-ylium chloride

C20H18NO4. Cl (371.0924)


Berberine chloride (TN) is an organic molecular entity. Berberine Chloride is the orally bioavailable, hydrochloride salt form of berberine, a quaternary ammonium salt of an isoquinoline alkaloid and active component of various Chinese herbs, with potential antineoplastic, radiosensitizing, anti-inflammatory, anti-lipidemic and antidiabetic activities. Although the mechanisms of action through which berberine exerts its effects are not yet fully elucidated, upon administration this agent appears to suppress the activation of various proteins and/or modulate the expression of a variety of genes involved in tumorigenesis and inflammation, including, but not limited to transcription factor nuclear factor-kappa B (NF-kB), myeloid cell leukemia 1 (Mcl-1), B-cell lymphoma 2 (Bcl-2), B-cell lymphoma-extra large (Bcl-xl), cyclooxygenase (COX)-2, tumor necrosis factor (TNF), interleukin (IL)-6, IL-12, inducible nitric oxide synthase (iNOS), intercellular adhesion molecule-1 (ICAM-1), E-selectin, monocyte chemoattractant protein-1 (MCP-1), C-X-C motif chemokine 2 (CXCL2), cyclin D1, activator protein (AP-1), hypoxia-inducible factor 1 (HIF-1), signal transducer and activator of transcription 3 (STAT3), peroxisome proliferator-activated receptor (PPAR), arylamine N-acetyltransferase (NAT), and DNA topoisomerase I and II. The modulation of gene expression may induce cell cycle arrest and apoptosis, and inhibit cancer cell proliferation. In addition, berberine modulates lipid and glucose metabolism. Berberine chloride is an alkaloid that acts as an antibiotic. Berberine chloride induces reactive oxygen species (ROS) generation and inhibits DNA topoisomerase. Antineoplastic properties[1]. Berberine chloride is an alkaloid that acts as an antibiotic. Berberine chloride induces reactive oxygen species (ROS) generation and inhibits DNA topoisomerase. Antineoplastic properties[1].

   

NEDOCROMIL

NEDOCROMIL

C19H17NO7 (371.1005)


R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03B - Other drugs for obstructive airway diseases, inhalants > R03BC - Antiallergic agents, excl. corticosteroids R - Respiratory system > R01 - Nasal preparations > R01A - Decongestants and other nasal preparations for topical use > R01AC - Antiallergic agents, excl. corticosteroids S - Sensory organs > S01 - Ophthalmologicals > S01G - Decongestants and antiallergics C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist D000893 - Anti-Inflammatory Agents > D000082142 - Mast Cell Stabilizers D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents D018926 - Anti-Allergic Agents D007155 - Immunologic Factors Nedocromil suppresses the action or formation of multiple mediators, including histamine, leukotriene C4 (LTC4), and prostaglandin D2 (PGD2).

   

Abt-751

ABT-751 (E7010)

C18H17N3O4S (371.094)


C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C273 - Antimitotic Agent

   

GMX1778

2-[6-(4-Chlorophenoxy)hexyl]-1-cyano-3-pyridin-4-ylguanidine

C19H22ClN5O (371.1513)


C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor

   

ent-glycosmisate

ent-glycosmisate

C20H19O7 (371.1131)


A monocarboxylic acid anion that is the conjugate base of ent-glycosmisic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

Amocarzine

Amocarzine

C18H21N5O2S (371.1416)


D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000871 - Anthelmintics C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C250 - Antihelminthic Agent

   

N-Methyl-14-O-demethylepiporphyroxine

N-Methyl-14-O-demethylepiporphyroxine

C20H21NO6 (371.1369)


   

4-(2-amino-3-hydroxyphenyl)-4-oxobutanoic acid O-glucoside

4-(2-amino-3-hydroxyphenyl)-4-oxobutanoic acid O-glucoside

C16H21NO9 (371.1216)


   

Salicyluric beta-D-glucuronide

Salicyluric beta-D-glucuronide

C15H17NO10 (371.0852)


   

N,N-dimethyl-2-oxo-3-(4,5,6,7-tetrahydro-1H-indol-2-ylmethylene)indoline-5-sulfonamide

N,N-dimethyl-2-oxo-3-(4,5,6,7-tetrahydro-1H-indol-2-ylmethylene)indoline-5-sulfonamide

C19H21N3O3S (371.1304)


   

glycosmisate

glycosmisate

C20H19O7 (371.1131)


A monocarboxylic acid anion that is the conjugate base of glycosmisic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

(-)-Demecolcine

(-)-Demecolcine

C21H25NO5 (371.1733)


A secondary amino compound that is (S)-colchicine in which the N-acetyl group is replaced by an N-methyl group. Isolable from the autumn crocus, Colchicum autumnale, it is less toxic than colchicine and is used as an antineoplastic.

   
   
   
   

O-Acetylsalutaridinol

O-Acetylsalutaridinol

C21H25NO5 (371.1733)


   

ST 19:5;O3;Gly

ST 19:5;O3;Gly

C21H25NO5 (371.1733)


   

FITM

FITM

C18H18FN5OS (371.1216)


FITM is a negative allosteric modulator of mGlu1 receptor with a Ki of 2.5 nM.

   

Quinotolast sodium

Quinotolast sodium

C17H12N6NaO3 (371.0869)


Quinotolast sodium in the concentration range of 1-100 μg/mL inhibits histamine, LTC4 and PGD2 release in a concentration-dependent manner.

   

VUF-5574

VUF-5574

C21H17N5O2 (371.1382)


VUF-5574 is a selective antagonist of adenosine A3 receptor with a Ki of 4.03 nM for the recombinant human receptor[1].

   

Z16078526

Z16078526

C18H17N3O4S (371.094)


Z16078526 induces endogenous Ucp1 expression, promotes p38 MAPK phosphorylation and lipolysis in primary mouse brown adipocytes. Z16078526 activates thermogenic gene expression and mitochondrial activity (uncoupled respiration) in mouse brown adipocytes. Z16078526 also stimulates thermogenesis in the mouse[1].

   

(1r)-11,17-dimethoxy-6,8,12-trioxa-22-azapentacyclo[11.9.0.0²,¹⁰.0⁵,⁹.0¹⁴,¹⁹]docosa-2(10),3,5(9),14(19),15,17-hexaen-16-ol

(1r)-11,17-dimethoxy-6,8,12-trioxa-22-azapentacyclo[11.9.0.0²,¹⁰.0⁵,⁹.0¹⁴,¹⁹]docosa-2(10),3,5(9),14(19),15,17-hexaen-16-ol

C20H21NO6 (371.1369)


   

n-{5-hydroxy-3,4,14-trimethoxy-13-oxotricyclo[9.5.0.0²,⁷]hexadeca-1(16),2,4,6,11,14-hexaen-10-yl}carboximidic acid

n-{5-hydroxy-3,4,14-trimethoxy-13-oxotricyclo[9.5.0.0²,⁷]hexadeca-1(16),2,4,6,11,14-hexaen-10-yl}carboximidic acid

C20H21NO6 (371.1369)


   

(1s)-5,6,7-trimethoxy-1-[(6-methyl-2h-1,3-benzodioxol-5-yl)methyl]-1,2,3,4-tetrahydroisoquinoline

(1s)-5,6,7-trimethoxy-1-[(6-methyl-2h-1,3-benzodioxol-5-yl)methyl]-1,2,3,4-tetrahydroisoquinoline

C21H25NO5 (371.1733)


   

13-hydroxy-15,16-dimethoxy-11-methyl-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8(20),14,16,18-hexaen-11-ium-11-olate

13-hydroxy-15,16-dimethoxy-11-methyl-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8(20),14,16,18-hexaen-11-ium-11-olate

C20H21NO6 (371.1369)


   

(6r,12br)-2,3,10,11-tetramethoxy-7,8,12b,13-tetrahydro-5h-6-azatetraphen-6-ium-6-olate

(6r,12br)-2,3,10,11-tetramethoxy-7,8,12b,13-tetrahydro-5h-6-azatetraphen-6-ium-6-olate

C21H25NO5 (371.1733)


   

n-[(10s)-4-hydroxy-3,5,14-trimethoxy-13-oxotricyclo[9.5.0.0²,⁷]hexadeca-1(16),2(7),3,5,11,14-hexaen-10-yl]carboximidic acid

n-[(10s)-4-hydroxy-3,5,14-trimethoxy-13-oxotricyclo[9.5.0.0²,⁷]hexadeca-1(16),2(7),3,5,11,14-hexaen-10-yl]carboximidic acid

C20H21NO6 (371.1369)


   

14-acetyl-5-hydroxy-9-methyl-4,10-dioxa-14-azapentacyclo[11.7.0.0¹,⁵.0⁷,¹².0¹⁵,²⁰]icosa-15,17,19-triene-8-carbaldehyde

14-acetyl-5-hydroxy-9-methyl-4,10-dioxa-14-azapentacyclo[11.7.0.0¹,⁵.0⁷,¹².0¹⁵,²⁰]icosa-15,17,19-triene-8-carbaldehyde

C21H25NO5 (371.1733)


   

n-[(10s,12r,16s)-5-hydroxy-3,4,14-trimethoxy-13-oxotetracyclo[9.5.0.0²,⁷.0¹²,¹⁶]hexadeca-1(11),2,4,6,14-pentaen-10-yl]carboximidic acid

n-[(10s,12r,16s)-5-hydroxy-3,4,14-trimethoxy-13-oxotetracyclo[9.5.0.0²,⁷.0¹²,¹⁶]hexadeca-1(11),2,4,6,14-pentaen-10-yl]carboximidic acid

C20H21NO6 (371.1369)


   

(2s)-4,9-dihydroxy-2-(2-hydroxypropan-2-yl)-11-methoxy-10-methyl-2h,3h-furo[3,2-b]acridin-5-one

(2s)-4,9-dihydroxy-2-(2-hydroxypropan-2-yl)-11-methoxy-10-methyl-2h,3h-furo[3,2-b]acridin-5-one

C20H21NO6 (371.1369)


   

4,16,17-trimethoxy-11-methyl-11-azatetracyclo[8.7.1.0²,⁷.0¹⁴,¹⁸]octadeca-1(17),2(7),3,5,14(18),15-hexaene-3,5-diol

4,16,17-trimethoxy-11-methyl-11-azatetracyclo[8.7.1.0²,⁷.0¹⁴,¹⁸]octadeca-1(17),2(7),3,5,14(18),15-hexaene-3,5-diol

C21H25NO5 (371.1733)


   

(2s)-n-{6-[(r)-(acetyloxy)(phenyl)methyl]-4-oxopyran-3-carbonyl}-2-methylbutanimidic acid

(2s)-n-{6-[(r)-(acetyloxy)(phenyl)methyl]-4-oxopyran-3-carbonyl}-2-methylbutanimidic acid

C20H21NO6 (371.1369)


   

5,6,7-trimethoxy-1-[(6-methyl-2h-1,3-benzodioxol-5-yl)methyl]-1,2,3,4-tetrahydroisoquinoline

5,6,7-trimethoxy-1-[(6-methyl-2h-1,3-benzodioxol-5-yl)methyl]-1,2,3,4-tetrahydroisoquinoline

C21H25NO5 (371.1733)


   

(12br)-2,3,10,11-tetramethoxy-7,8,12b,13-tetrahydro-5h-6-azatetraphen-6-ium-6-olate

(12br)-2,3,10,11-tetramethoxy-7,8,12b,13-tetrahydro-5h-6-azatetraphen-6-ium-6-olate

C21H25NO5 (371.1733)


   

5-hydroxy-2-[hydroxy(4-hydroxyphenyl)methyl]-4-(1-hydroxy-4,6-dimethylocta-2,4-dien-1-ylidene)-2h-pyrrol-3-one

5-hydroxy-2-[hydroxy(4-hydroxyphenyl)methyl]-4-(1-hydroxy-4,6-dimethylocta-2,4-dien-1-ylidene)-2h-pyrrol-3-one

C21H25NO5 (371.1733)


   

(2e)-4-({4,8-dimethoxyfuro[2,3-b]quinolin-7-yl}oxy)-2-methylbut-2-en-1-yl acetate

(2e)-4-({4,8-dimethoxyfuro[2,3-b]quinolin-7-yl}oxy)-2-methylbut-2-en-1-yl acetate

C20H21NO6 (371.1369)


   

(5s,9bs,11r)-7,8,11-trimethoxy-2h,4h,5h,10h,11h-indolo[7a,1-a]isoquinolin-5-yl acetate

(5s,9bs,11r)-7,8,11-trimethoxy-2h,4h,5h,10h,11h-indolo[7a,1-a]isoquinolin-5-yl acetate

C21H25NO5 (371.1733)


   

10-(dimethylamino)-5-hydroxy-3,4,14-trimethoxytricyclo[9.5.0.0²,⁷]hexadeca-1(16),2,4,6,11,14-hexaen-13-one

10-(dimethylamino)-5-hydroxy-3,4,14-trimethoxytricyclo[9.5.0.0²,⁷]hexadeca-1(16),2,4,6,11,14-hexaen-13-one

C21H25NO5 (371.1733)


   

3,4,10,11-tetramethoxy-7,8,12b,13-tetrahydro-5h-6-azatetraphen-2-ol

3,4,10,11-tetramethoxy-7,8,12b,13-tetrahydro-5h-6-azatetraphen-2-ol

C21H25NO5 (371.1733)


   

6-methoxy-3-{7-methoxy-9h-pyrido[3,4-b]indole-1-carbonyl}-1h-indole

6-methoxy-3-{7-methoxy-9h-pyrido[3,4-b]indole-1-carbonyl}-1h-indole

C22H17N3O3 (371.127)


   

(10r)-3,4,5,14-tetramethoxy-10-(methylamino)tricyclo[9.5.0.0²,⁷]hexadeca-1(16),2,4,6,11,14-hexaen-13-one

(10r)-3,4,5,14-tetramethoxy-10-(methylamino)tricyclo[9.5.0.0²,⁷]hexadeca-1(16),2,4,6,11,14-hexaen-13-one

C21H25NO5 (371.1733)


   

(9s)-4,5,14,15,16-pentamethoxy-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2(7),3,5,13(17),14-hexaene

(9s)-4,5,14,15,16-pentamethoxy-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2(7),3,5,13(17),14-hexaene

C21H25NO5 (371.1733)


   

16-oxodelavaine

NA

C20H21NO6 (371.1369)


{"Ingredient_id": "HBIN001942","Ingredient_name": "16-oxodelavaine","Alias": "NA","Ingredient_formula": "C20H21NO6","Ingredient_Smile": "CN1C2CC3=CC4=C(C=C3C5(C2C(=C(C(=O)C5)OC)OC)CC1=O)OCO4","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "16299","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

acutifolidine; (s)-form

NA

C21H25NO5 (371.1733)


{"Ingredient_id": "HBIN014655","Ingredient_name": "acutifolidine; (s)-form","Alias": "NA","Ingredient_formula": "C21H25NO5","Ingredient_Smile": "NA","Ingredient_weight": "371.43","OB_score": "NA","CAS_id": "126595-93-5","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "7166","PubChem_id": "NA","DrugBank_id": "NA"}

   

(2e,4e,6r)-1-[(5s)-2,4-dihydroxy-5-[(r)-hydroxy(4-hydroxyphenyl)methyl]-5h-pyrrol-3-yl]-4,6-dimethylocta-2,4-dien-1-one

(2e,4e,6r)-1-[(5s)-2,4-dihydroxy-5-[(r)-hydroxy(4-hydroxyphenyl)methyl]-5h-pyrrol-3-yl]-4,6-dimethylocta-2,4-dien-1-one

C21H25NO5 (371.1733)


   

(2s)-1-({4,8-dimethoxyfuro[2,3-b]quinolin-7-yl}oxy)-3-methylbut-3-en-2-yl acetate

(2s)-1-({4,8-dimethoxyfuro[2,3-b]quinolin-7-yl}oxy)-3-methylbut-3-en-2-yl acetate

C20H21NO6 (371.1369)


   

3,5,17-trimethoxy-11-methyl-11-azatetracyclo[8.7.1.0²,⁷.0¹⁴,¹⁸]octadeca-1(17),2(7),3,5,14(18),15-hexaene-4,16-diol

3,5,17-trimethoxy-11-methyl-11-azatetracyclo[8.7.1.0²,⁷.0¹⁴,¹⁸]octadeca-1(17),2(7),3,5,14(18),15-hexaene-4,16-diol

C21H25NO5 (371.1733)


   

methyl 7-[2-(dimethylamino)ethyl]-10-hydroxy-9-methoxy-1-oxobenzo[h]isochromene-3-carboxylate

methyl 7-[2-(dimethylamino)ethyl]-10-hydroxy-9-methoxy-1-oxobenzo[h]isochromene-3-carboxylate

C20H21NO6 (371.1369)


   

(10s)-3,5,17-trimethoxy-11-methyl-11-azatetracyclo[8.7.1.0²,⁷.0¹⁴,¹⁸]octadeca-1(17),2(7),3,5,14(18),15-hexaene-4,16-diol

(10s)-3,5,17-trimethoxy-11-methyl-11-azatetracyclo[8.7.1.0²,⁷.0¹⁴,¹⁸]octadeca-1(17),2(7),3,5,14(18),15-hexaene-4,16-diol

C21H25NO5 (371.1733)


   

3-(3,4-dimethoxyphenyl)-n-[2-(3,4-dimethoxyphenyl)ethyl]prop-2-enimidic acid

3-(3,4-dimethoxyphenyl)-n-[2-(3,4-dimethoxyphenyl)ethyl]prop-2-enimidic acid

C21H25NO5 (371.1733)


   

(2s,3s,4s,5s,6r)-6-[(1s)-2-{[(2s,3r,4r,5s,6r)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1-hydroxyethyl]oxane-2,3,4,5-tetrol

(2s,3s,4s,5s,6r)-6-[(1s)-2-{[(2s,3r,4r,5s,6r)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1-hydroxyethyl]oxane-2,3,4,5-tetrol

C13H25NO11 (371.1428)


   

(7s,8r)-7',8-dihydroxy-6'-methoxy-2'-methyl-3',4',6,8-tetrahydro-2h-spiro[indeno[4,5-d][1,3]dioxole-7,1'-isoquinolin]-2'-ium-2'-olate

(7s,8r)-7',8-dihydroxy-6'-methoxy-2'-methyl-3',4',6,8-tetrahydro-2h-spiro[indeno[4,5-d][1,3]dioxole-7,1'-isoquinolin]-2'-ium-2'-olate

C20H21NO6 (371.1369)


   

n-[(10s)-4,14-dihydroxy-3,5-dimethoxy-13-oxotricyclo[9.5.0.0²,⁷]hexadeca-1(16),2(7),3,5,11,14-hexaen-10-yl]ethanimidic acid

n-[(10s)-4,14-dihydroxy-3,5-dimethoxy-13-oxotricyclo[9.5.0.0²,⁷]hexadeca-1(16),2(7),3,5,11,14-hexaen-10-yl]ethanimidic acid

C20H21NO6 (371.1369)


   

(9s)-4,5,15,16-tetramethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2(7),3,5,13(17),14-hexaen-14-ol

(9s)-4,5,15,16-tetramethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2(7),3,5,13(17),14-hexaen-14-ol

C21H25NO5 (371.1733)


   

4,5,16-trimethoxy-11-methyl-11-azatetracyclo[8.7.1.0²,⁷.0¹⁴,¹⁸]octadeca-1(17),2(7),3,5,14(18),15-hexaene-3,17-diol

4,5,16-trimethoxy-11-methyl-11-azatetracyclo[8.7.1.0²,⁷.0¹⁴,¹⁸]octadeca-1(17),2(7),3,5,14(18),15-hexaene-3,17-diol

C21H25NO5 (371.1733)


   

(12s)-7,16,17-trimethoxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,14(19),15,17-hexaen-15-ol

(12s)-7,16,17-trimethoxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,14(19),15,17-hexaen-15-ol

C20H21NO6 (371.1369)


   

17-(acetyloxy)-5,7-dioxa-12-azapentacyclo[10.6.1.0²,¹⁰.0⁴,⁸.0¹⁵,¹⁹]nonadeca-2,4(8),9,15-tetraen-18-yl acetate

17-(acetyloxy)-5,7-dioxa-12-azapentacyclo[10.6.1.0²,¹⁰.0⁴,⁸.0¹⁵,¹⁹]nonadeca-2,4(8),9,15-tetraen-18-yl acetate

C20H21NO6 (371.1369)


   

3,5,8-trihydroxy-6-methoxy-2,2,7-trimethyl-3,4-dihydro-1-oxa-7-azatetraphen-12-one

3,5,8-trihydroxy-6-methoxy-2,2,7-trimethyl-3,4-dihydro-1-oxa-7-azatetraphen-12-one

C20H21NO6 (371.1369)


   

(12s,13s)-13-hydroxy-15,16-dimethoxy-11-methyl-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8(20),14,16,18-hexaen-11-ium-11-olate

(12s,13s)-13-hydroxy-15,16-dimethoxy-11-methyl-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8(20),14,16,18-hexaen-11-ium-11-olate

C20H21NO6 (371.1369)


   

(6r,12bs)-3,4,10,11-tetramethoxy-7,8,12b,13-tetrahydro-5h-6-azatetraphen-6-ium-6-olate

(6r,12bs)-3,4,10,11-tetramethoxy-7,8,12b,13-tetrahydro-5h-6-azatetraphen-6-ium-6-olate

C21H25NO5 (371.1733)


   

6-[(5s)-2h,5h,6h,7h,8h-[1,3]dioxolo[4,5-g]isoquinolin-5-ylmethyl]-2,3-dimethoxybenzoic acid

6-[(5s)-2h,5h,6h,7h,8h-[1,3]dioxolo[4,5-g]isoquinolin-5-ylmethyl]-2,3-dimethoxybenzoic acid

C20H21NO6 (371.1369)


   

(12bs)-3,4,10,11-tetramethoxy-7,8,12b,13-tetrahydro-5h-6-azatetraphen-2-ol

(12bs)-3,4,10,11-tetramethoxy-7,8,12b,13-tetrahydro-5h-6-azatetraphen-2-ol

C21H25NO5 (371.1733)


   

methyl 3-(5-hydroxy-1h-indol-3-yl)-4-(1h-indol-3-yl)-1h-pyrrole-2-carboxylate

methyl 3-(5-hydroxy-1h-indol-3-yl)-4-(1h-indol-3-yl)-1h-pyrrole-2-carboxylate

C22H17N3O3 (371.127)


   

n-{5,14-dihydroxy-3,4-dimethoxy-13-oxotricyclo[9.5.0.0²,⁷]hexadeca-1(16),2,4,6,11,14-hexaen-10-yl}ethanimidic acid

n-{5,14-dihydroxy-3,4-dimethoxy-13-oxotricyclo[9.5.0.0²,⁷]hexadeca-1(16),2,4,6,11,14-hexaen-10-yl}ethanimidic acid

C20H21NO6 (371.1369)


   

10-(2-hydroxypropyl)-4,16-dimethoxy-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2,4,6,13(17),14-hexaene-3,15-diol

10-(2-hydroxypropyl)-4,16-dimethoxy-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2,4,6,13(17),14-hexaene-3,15-diol

C21H25NO5 (371.1733)


   

(12bs)-3,4,10,11-tetramethoxy-7,8,12b,13-tetrahydro-5h-6-azatetraphen-6-ium-6-olate

(12bs)-3,4,10,11-tetramethoxy-7,8,12b,13-tetrahydro-5h-6-azatetraphen-6-ium-6-olate

C21H25NO5 (371.1733)


   

n-[2-(4-methoxyphenyl)ethyl]-3-(3,4,5-trimethoxyphenyl)prop-2-enimidic acid

n-[2-(4-methoxyphenyl)ethyl]-3-(3,4,5-trimethoxyphenyl)prop-2-enimidic acid

C21H25NO5 (371.1733)


   

n-[(10r)-5-hydroxy-3,4,14-trimethoxy-13-oxotricyclo[9.5.0.0²,⁷]hexadeca-1(16),2,4,6,11,14-hexaen-10-yl]carboximidic acid

n-[(10r)-5-hydroxy-3,4,14-trimethoxy-13-oxotricyclo[9.5.0.0²,⁷]hexadeca-1(16),2,4,6,11,14-hexaen-10-yl]carboximidic acid

C20H21NO6 (371.1369)


   

(6s,12br)-3,4,10,11-tetramethoxy-7,8,12b,13-tetrahydro-5h-6-azatetraphen-6-ium-6-olate

(6s,12br)-3,4,10,11-tetramethoxy-7,8,12b,13-tetrahydro-5h-6-azatetraphen-6-ium-6-olate

C21H25NO5 (371.1733)


   

6-(2-{[3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1-hydroxyethyl)oxane-2,3,4,5-tetrol

6-(2-{[3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1-hydroxyethyl)oxane-2,3,4,5-tetrol

C13H25NO11 (371.1428)


   

11,17-dimethoxy-6,8,12-trioxa-22-azapentacyclo[11.9.0.0²,¹⁰.0⁵,⁹.0¹⁴,¹⁹]docosa-2(10),3,5(9),14(19),15,17-hexaen-16-ol

11,17-dimethoxy-6,8,12-trioxa-22-azapentacyclo[11.9.0.0²,¹⁰.0⁵,⁹.0¹⁴,¹⁹]docosa-2(10),3,5(9),14(19),15,17-hexaen-16-ol

C20H21NO6 (371.1369)


   

(10s)-3,4,16-trimethoxy-11-methyl-11-azatetracyclo[8.7.1.0²,⁷.0¹⁴,¹⁸]octadeca-1(17),2(7),3,5,14(18),15-hexaene-5,17-diol

(10s)-3,4,16-trimethoxy-11-methyl-11-azatetracyclo[8.7.1.0²,⁷.0¹⁴,¹⁸]octadeca-1(17),2(7),3,5,14(18),15-hexaene-5,17-diol

C21H25NO5 (371.1733)


   

(6s,12br)-2,3,10,11-tetramethoxy-7,8,12b,13-tetrahydro-5h-6-azatetraphen-6-ium-6-olate

(6s,12br)-2,3,10,11-tetramethoxy-7,8,12b,13-tetrahydro-5h-6-azatetraphen-6-ium-6-olate

C21H25NO5 (371.1733)


   

(2s)-4-[(2e,4e,6s,7s)-1,7-dihydroxy-4,6-dimethylocta-2,4-dien-1-ylidene]-5-hydroxy-2-[(4-hydroxyphenyl)methyl]-2h-pyrrol-3-one

(2s)-4-[(2e,4e,6s,7s)-1,7-dihydroxy-4,6-dimethylocta-2,4-dien-1-ylidene]-5-hydroxy-2-[(4-hydroxyphenyl)methyl]-2h-pyrrol-3-one

C21H25NO5 (371.1733)


   

(1s,17s,18s,19s)-17-(acetyloxy)-5,7-dioxa-12-azapentacyclo[10.6.1.0²,¹⁰.0⁴,⁸.0¹⁵,¹⁹]nonadeca-2,4(8),9,15-tetraen-18-yl acetate

(1s,17s,18s,19s)-17-(acetyloxy)-5,7-dioxa-12-azapentacyclo[10.6.1.0²,¹⁰.0⁴,⁸.0¹⁵,¹⁹]nonadeca-2,4(8),9,15-tetraen-18-yl acetate

C20H21NO6 (371.1369)


   

4,14,15,16-tetramethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2(7),3,5,13(17),14-hexaen-5-ol

4,14,15,16-tetramethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2(7),3,5,13(17),14-hexaen-5-ol

C21H25NO5 (371.1733)


   

6-[(7-hydroxy-2-methyl-6-oxo-3,4-dihydroisoquinolin-1-yl)methyl]-2,3-dimethoxybenzoic acid

6-[(7-hydroxy-2-methyl-6-oxo-3,4-dihydroisoquinolin-1-yl)methyl]-2,3-dimethoxybenzoic acid

C20H21NO6 (371.1369)


   

2,3,10,11-tetramethoxy-7,8,12b,13-tetrahydro-5h-6-azatetraphen-12-ol

2,3,10,11-tetramethoxy-7,8,12b,13-tetrahydro-5h-6-azatetraphen-12-ol

C21H25NO5 (371.1733)


   

n-{4-hydroxy-3,5,14-trimethoxy-13-oxotricyclo[9.5.0.0²,⁷]hexadeca-1(16),2(7),3,5,11,14-hexaen-10-yl}carboximidic acid

n-{4-hydroxy-3,5,14-trimethoxy-13-oxotricyclo[9.5.0.0²,⁷]hexadeca-1(16),2(7),3,5,11,14-hexaen-10-yl}carboximidic acid

C20H21NO6 (371.1369)


   

4,5,14,16-tetramethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2(7),3,5,13(17),14-hexaen-15-ol

4,5,14,16-tetramethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2(7),3,5,13(17),14-hexaen-15-ol

C21H25NO5 (371.1733)


   

n-[(10s)-4,5-dihydroxy-3,14-dimethoxy-13-oxotricyclo[9.5.0.0²,⁷]hexadeca-1(16),2(7),3,5,11,14-hexaen-10-yl]ethanimidic acid

n-[(10s)-4,5-dihydroxy-3,14-dimethoxy-13-oxotricyclo[9.5.0.0²,⁷]hexadeca-1(16),2(7),3,5,11,14-hexaen-10-yl]ethanimidic acid

C20H21NO6 (371.1369)


   

4-({4,8-dimethoxyfuro[2,3-b]quinolin-7-yl}oxy)-2-methylbut-2-en-1-yl acetate

4-({4,8-dimethoxyfuro[2,3-b]quinolin-7-yl}oxy)-2-methylbut-2-en-1-yl acetate

C20H21NO6 (371.1369)


   

4,9-dihydroxy-2-(2-hydroxypropan-2-yl)-11-methoxy-10-methyl-2h,3h-furo[3,2-b]acridin-5-one

4,9-dihydroxy-2-(2-hydroxypropan-2-yl)-11-methoxy-10-methyl-2h,3h-furo[3,2-b]acridin-5-one

C20H21NO6 (371.1369)


   

3,4,10,11-tetramethoxy-7,8,12b,13-tetrahydro-5h-6-azatetraphen-9-ol

3,4,10,11-tetramethoxy-7,8,12b,13-tetrahydro-5h-6-azatetraphen-9-ol

C21H25NO5 (371.1733)


   

n-{4,5-dihydroxy-3,14-dimethoxy-13-oxotricyclo[9.5.0.0²,⁷]hexadeca-1(16),2(7),3,5,11,14-hexaen-10-yl}ethanimidic acid

n-{4,5-dihydroxy-3,14-dimethoxy-13-oxotricyclo[9.5.0.0²,⁷]hexadeca-1(16),2(7),3,5,11,14-hexaen-10-yl}ethanimidic acid

C20H21NO6 (371.1369)


   

n-{4,14-dihydroxy-3,5-dimethoxy-13-oxotricyclo[9.5.0.0²,⁷]hexadeca-1(16),2(7),3,5,11,14-hexaen-10-yl}ethanimidic acid

n-{4,14-dihydroxy-3,5-dimethoxy-13-oxotricyclo[9.5.0.0²,⁷]hexadeca-1(16),2(7),3,5,11,14-hexaen-10-yl}ethanimidic acid

C20H21NO6 (371.1369)


   

(1s,5s,7r,8s,9r,12r,13s)-14-acetyl-5-hydroxy-9-methyl-4,10-dioxa-14-azapentacyclo[11.7.0.0¹,⁵.0⁷,¹².0¹⁵,²⁰]icosa-15,17,19-triene-8-carbaldehyde

(1s,5s,7r,8s,9r,12r,13s)-14-acetyl-5-hydroxy-9-methyl-4,10-dioxa-14-azapentacyclo[11.7.0.0¹,⁵.0⁷,¹².0¹⁵,²⁰]icosa-15,17,19-triene-8-carbaldehyde

C21H25NO5 (371.1733)


   

(10s)-3,4,17-trimethoxy-11-methyl-11-azatetracyclo[8.7.1.0²,⁷.0¹⁴,¹⁸]octadeca-1(17),2,4,6,14(18),15-hexaene-5,16-diol

(10s)-3,4,17-trimethoxy-11-methyl-11-azatetracyclo[8.7.1.0²,⁷.0¹⁴,¹⁸]octadeca-1(17),2,4,6,14(18),15-hexaene-5,16-diol

C21H25NO5 (371.1733)


   

(9r)-4,5,14,16-tetramethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2(7),3,5,13(17),14-hexaen-15-ol

(9r)-4,5,14,16-tetramethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2(7),3,5,13(17),14-hexaen-15-ol

C21H25NO5 (371.1733)


   

3,11-dihydroxy-2,4,10-trimethoxy-7,8,12b,13-tetrahydro-6-azatetraphen-5-one

3,11-dihydroxy-2,4,10-trimethoxy-7,8,12b,13-tetrahydro-6-azatetraphen-5-one

C20H21NO6 (371.1369)


   

(6s,12bs)-3,4,10,11-tetramethoxy-7,8,12b,13-tetrahydro-5h-6-azatetraphen-6-ium-6-olate

(6s,12bs)-3,4,10,11-tetramethoxy-7,8,12b,13-tetrahydro-5h-6-azatetraphen-6-ium-6-olate

C21H25NO5 (371.1733)


   

3-[(2s)-butan-2-yl]-4-{4-[(3-methylbut-2-en-1-yl)oxy]phenyl}-2,5-dioxopyrrol-1-yl acetate

3-[(2s)-butan-2-yl]-4-{4-[(3-methylbut-2-en-1-yl)oxy]phenyl}-2,5-dioxopyrrol-1-yl acetate

C21H25NO5 (371.1733)


   

1-{6-[2-(dimethylamino)ethyl]-2h-1,3-benzodioxol-5-yl}-2-(3-hydroxy-4-methoxyphenyl)ethane-1,2-dione

1-{6-[2-(dimethylamino)ethyl]-2h-1,3-benzodioxol-5-yl}-2-(3-hydroxy-4-methoxyphenyl)ethane-1,2-dione

C20H21NO6 (371.1369)


   

(10s)-3,5,16-trimethoxy-11-methyl-11-azatetracyclo[8.7.1.0²,⁷.0¹⁴,¹⁸]octadeca-1(17),2(7),3,5,14(18),15-hexaene-4,17-diol

(10s)-3,5,16-trimethoxy-11-methyl-11-azatetracyclo[8.7.1.0²,⁷.0¹⁴,¹⁸]octadeca-1(17),2(7),3,5,14(18),15-hexaene-4,17-diol

C21H25NO5 (371.1733)


   

(12bs)-3,4,10,11-tetramethoxy-7,8,12b,13-tetrahydro-5h-6-azatetraphen-9-ol

(12bs)-3,4,10,11-tetramethoxy-7,8,12b,13-tetrahydro-5h-6-azatetraphen-9-ol

C21H25NO5 (371.1733)


   

(2e)-n-[2-(4-methoxyphenyl)ethyl]-3-(3,4,5-trimethoxyphenyl)prop-2-enimidic acid

(2e)-n-[2-(4-methoxyphenyl)ethyl]-3-(3,4,5-trimethoxyphenyl)prop-2-enimidic acid

C21H25NO5 (371.1733)


   

n-[(10r)-5,14-dihydroxy-3,4-dimethoxy-13-oxotricyclo[9.5.0.0²,⁷]hexadeca-1(16),2,4,6,11,14-hexaen-10-yl]ethanimidic acid

n-[(10r)-5,14-dihydroxy-3,4-dimethoxy-13-oxotricyclo[9.5.0.0²,⁷]hexadeca-1(16),2,4,6,11,14-hexaen-10-yl]ethanimidic acid

C20H21NO6 (371.1369)


   

(2e)-3-(4-hydroxy-3-methoxyphenyl)-n-[(2s)-2-(4-hydroxyphenyl)-2-propoxyethyl]prop-2-enimidic acid

(2e)-3-(4-hydroxy-3-methoxyphenyl)-n-[(2s)-2-(4-hydroxyphenyl)-2-propoxyethyl]prop-2-enimidic acid

C21H25NO5 (371.1733)


   

10-hydroxy-5,7-dimethyl-12-methylidene-16-oxa-7-azahexacyclo[9.7.2.0¹,⁸.0⁵,¹⁸.0⁹,¹⁴.0¹⁴,¹⁹]icosane-3,15,17-trione

10-hydroxy-5,7-dimethyl-12-methylidene-16-oxa-7-azahexacyclo[9.7.2.0¹,⁸.0⁵,¹⁸.0⁹,¹⁴.0¹⁴,¹⁹]icosane-3,15,17-trione

C21H25NO5 (371.1733)


   

3,4,16-trimethoxy-11-methyl-11-azatetracyclo[8.7.1.0²,⁷.0¹⁴,¹⁸]octadeca-1(17),2(7),3,5,14(18),15-hexaene-5,17-diol

3,4,16-trimethoxy-11-methyl-11-azatetracyclo[8.7.1.0²,⁷.0¹⁴,¹⁸]octadeca-1(17),2(7),3,5,14(18),15-hexaene-5,17-diol

C21H25NO5 (371.1733)


   

(1s,5r,8s,9s,10s,11s,14r,18r,19s)-10-hydroxy-5,7-dimethyl-12-methylidene-16-oxa-7-azahexacyclo[9.7.2.0¹,⁸.0⁵,¹⁸.0⁹,¹⁴.0¹⁴,¹⁹]icosane-3,15,17-trione

(1s,5r,8s,9s,10s,11s,14r,18r,19s)-10-hydroxy-5,7-dimethyl-12-methylidene-16-oxa-7-azahexacyclo[9.7.2.0¹,⁸.0⁵,¹⁸.0⁹,¹⁴.0¹⁴,¹⁹]icosane-3,15,17-trione

C21H25NO5 (371.1733)


   

(9s)-4,5,14,15-tetramethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2(7),3,5,13(17),14-hexaen-16-ol

(9s)-4,5,14,15-tetramethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2(7),3,5,13(17),14-hexaen-16-ol

C21H25NO5 (371.1733)


   

(10r)-3,4,16-trimethoxy-11-methyl-11-azatetracyclo[8.7.1.0²,⁷.0¹⁴,¹⁸]octadeca-1(17),2(7),3,5,14(18),15-hexaene-5,17-diol

(10r)-3,4,16-trimethoxy-11-methyl-11-azatetracyclo[8.7.1.0²,⁷.0¹⁴,¹⁸]octadeca-1(17),2(7),3,5,14(18),15-hexaene-5,17-diol

C21H25NO5 (371.1733)


   

6-[(5r)-2h,5h,6h,7h,8h-[1,3]dioxolo[4,5-g]isoquinolin-5-ylmethyl]-2,3-dimethoxybenzoic acid

6-[(5r)-2h,5h,6h,7h,8h-[1,3]dioxolo[4,5-g]isoquinolin-5-ylmethyl]-2,3-dimethoxybenzoic acid

C20H21NO6 (371.1369)


   

(1r,11r,13s)-11,17-dimethoxy-6,8,12-trioxa-22-azapentacyclo[11.9.0.0²,¹⁰.0⁵,⁹.0¹⁴,¹⁹]docosa-2(10),3,5(9),14(19),15,17-hexaen-16-ol

(1r,11r,13s)-11,17-dimethoxy-6,8,12-trioxa-22-azapentacyclo[11.9.0.0²,¹⁰.0⁵,⁹.0¹⁴,¹⁹]docosa-2(10),3,5(9),14(19),15,17-hexaen-16-ol

C20H21NO6 (371.1369)


   

(3r)-3-hydroxy-3-methyl-4-(1,4,5-trihydroxy-9,10-dioxoanthracen-2-yl)butanimidic acid

(3r)-3-hydroxy-3-methyl-4-(1,4,5-trihydroxy-9,10-dioxoanthracen-2-yl)butanimidic acid

C19H17NO7 (371.1005)


   

(11s,12s,13s)-13-hydroxy-15,16-dimethoxy-11-methyl-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8(20),14,16,18-hexaen-11-ium-11-olate

(11s,12s,13s)-13-hydroxy-15,16-dimethoxy-11-methyl-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8(20),14,16,18-hexaen-11-ium-11-olate

C20H21NO6 (371.1369)


   

(1s,11s,13s)-11,17-dimethoxy-6,8,12-trioxa-22-azapentacyclo[11.9.0.0²,¹⁰.0⁵,⁹.0¹⁴,¹⁹]docosa-2(10),3,5(9),14(19),15,17-hexaen-16-ol

(1s,11s,13s)-11,17-dimethoxy-6,8,12-trioxa-22-azapentacyclo[11.9.0.0²,¹⁰.0⁵,⁹.0¹⁴,¹⁹]docosa-2(10),3,5(9),14(19),15,17-hexaen-16-ol

C20H21NO6 (371.1369)


   

n-{6-[(r)-(acetyloxy)(phenyl)methyl]-4-oxopyran-3-carbonyl}-3-methylbutanimidic acid

n-{6-[(r)-(acetyloxy)(phenyl)methyl]-4-oxopyran-3-carbonyl}-3-methylbutanimidic acid

C20H21NO6 (371.1369)


   

(12bs)-3,11-dihydroxy-2,4,10-trimethoxy-7,8,12b,13-tetrahydro-6-azatetraphen-5-one

(12bs)-3,11-dihydroxy-2,4,10-trimethoxy-7,8,12b,13-tetrahydro-6-azatetraphen-5-one

C20H21NO6 (371.1369)


   

n-[(10s)-5-hydroxy-3,4,14-trimethoxy-13-oxotricyclo[9.5.0.0²,⁷]hexadeca-1(16),2,4,6,11,14-hexaen-10-yl]carboximidic acid

n-[(10s)-5-hydroxy-3,4,14-trimethoxy-13-oxotricyclo[9.5.0.0²,⁷]hexadeca-1(16),2,4,6,11,14-hexaen-10-yl]carboximidic acid

C20H21NO6 (371.1369)


   

5,6-dimethoxy-2-(2,3,6-trimethoxyphenyl)-1h-quinolin-4-one

5,6-dimethoxy-2-(2,3,6-trimethoxyphenyl)-1h-quinolin-4-one

C20H21NO6 (371.1369)


   

1-{[(2z)-4-({4,8-dimethoxyfuro[2,3-b]quinolin-7-yl}oxy)but-2-en-2-yl]oxy}propan-2-one

1-{[(2z)-4-({4,8-dimethoxyfuro[2,3-b]quinolin-7-yl}oxy)but-2-en-2-yl]oxy}propan-2-one

C20H21NO6 (371.1369)


   

methyl 3,4,8-trimethoxy-10-nitrophenanthrene-1-carboxylate

methyl 3,4,8-trimethoxy-10-nitrophenanthrene-1-carboxylate

C19H17NO7 (371.1005)


   

(6r,7s,8s)-6'-methoxy-2'-methyl-3',4',6,8-tetrahydro-2h-spiro[indeno[4,5-d][1,3]dioxole-7,1'-isoquinoline]-6,7',8-triol

(6r,7s,8s)-6'-methoxy-2'-methyl-3',4',6,8-tetrahydro-2h-spiro[indeno[4,5-d][1,3]dioxole-7,1'-isoquinoline]-6,7',8-triol

C20H21NO6 (371.1369)


   

14,15-dimethoxy-20-methyl-5,7-dioxa-20-azapentacyclo[11.4.3.0¹,¹³.0²,¹⁰.0⁴,⁸]icosa-2,4(8),9,14-tetraene-16,19-dione

14,15-dimethoxy-20-methyl-5,7-dioxa-20-azapentacyclo[11.4.3.0¹,¹³.0²,¹⁰.0⁴,⁸]icosa-2,4(8),9,14-tetraene-16,19-dione

C20H21NO6 (371.1369)


   

methyl 2-[(3z)-6-[2-(dimethylamino)ethyl]-9-hydroxy-8-methoxy-1-oxonaphtho[1,2-c]furan-3-ylidene]acetate

methyl 2-[(3z)-6-[2-(dimethylamino)ethyl]-9-hydroxy-8-methoxy-1-oxonaphtho[1,2-c]furan-3-ylidene]acetate

C20H21NO6 (371.1369)


   

(1s,13r)-14,15-dimethoxy-20-methyl-5,7-dioxa-20-azapentacyclo[11.4.3.0¹,¹³.0²,¹⁰.0⁴,⁸]icosa-2,4(8),9,14-tetraene-16,19-dione

(1s,13r)-14,15-dimethoxy-20-methyl-5,7-dioxa-20-azapentacyclo[11.4.3.0¹,¹³.0²,¹⁰.0⁴,⁸]icosa-2,4(8),9,14-tetraene-16,19-dione

C20H21NO6 (371.1369)


   

n-{5-hydroxy-3,4,14-trimethoxy-13-oxotetracyclo[9.5.0.0²,⁷.0¹²,¹⁶]hexadeca-1(11),2,4,6,14-pentaen-10-yl}carboximidic acid

n-{5-hydroxy-3,4,14-trimethoxy-13-oxotetracyclo[9.5.0.0²,⁷.0¹²,¹⁶]hexadeca-1(11),2,4,6,14-pentaen-10-yl}carboximidic acid

C20H21NO6 (371.1369)


   

5,6-dimethoxy-2-(2,3,5-trimethoxyphenyl)-1h-quinolin-4-one

5,6-dimethoxy-2-(2,3,5-trimethoxyphenyl)-1h-quinolin-4-one

C20H21NO6 (371.1369)


   

6'-methoxy-2'-methyl-3',4',6,8-tetrahydro-2h-spiro[indeno[4,5-d][1,3]dioxole-7,1'-isoquinoline]-6,7',8-triol

6'-methoxy-2'-methyl-3',4',6,8-tetrahydro-2h-spiro[indeno[4,5-d][1,3]dioxole-7,1'-isoquinoline]-6,7',8-triol

C20H21NO6 (371.1369)


   

n-{6-[(acetyloxy)(phenyl)methyl]-4-oxopyran-3-carbonyl}-3-methylbutanimidic acid

n-{6-[(acetyloxy)(phenyl)methyl]-4-oxopyran-3-carbonyl}-3-methylbutanimidic acid

C20H21NO6 (371.1369)


   

4-[4-(dimethylamino)-3,5,8,10-tetraazatetracyclo[7.7.0.0²,⁶.0¹¹,¹⁶]hexadeca-1,3,6,9,11,13,15-heptaene-7-carbonyl]phenol

4-[4-(dimethylamino)-3,5,8,10-tetraazatetracyclo[7.7.0.0²,⁶.0¹¹,¹⁶]hexadeca-1,3,6,9,11,13,15-heptaene-7-carbonyl]phenol

C21H17N5O2 (371.1382)